JP2003113040A - Antibacterial cosmetic composition - Google Patents
Antibacterial cosmetic compositionInfo
- Publication number
- JP2003113040A JP2003113040A JP2001308631A JP2001308631A JP2003113040A JP 2003113040 A JP2003113040 A JP 2003113040A JP 2001308631 A JP2001308631 A JP 2001308631A JP 2001308631 A JP2001308631 A JP 2001308631A JP 2003113040 A JP2003113040 A JP 2003113040A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- acid
- iturin
- oil
- antibacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 79
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 61
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 14
- 229940088594 vitamin Drugs 0.000 claims abstract description 14
- 229930003231 vitamin Natural products 0.000 claims abstract description 14
- 235000013343 vitamin Nutrition 0.000 claims abstract description 14
- 239000011782 vitamin Substances 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 13
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims description 20
- 150000001875 compounds Chemical class 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 5
- 206010000496 acne Diseases 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 206010012438 Dermatitis atopic Diseases 0.000 claims description 3
- 201000008937 atopic dermatitis Diseases 0.000 claims description 3
- 229940124597 therapeutic agent Drugs 0.000 claims description 3
- 230000000069 prophylactic effect Effects 0.000 claims description 2
- 210000000170 cell membrane Anatomy 0.000 abstract description 8
- 241000282414 Homo sapiens Species 0.000 abstract description 5
- 230000009471 action Effects 0.000 abstract description 5
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- 239000000284 extract Substances 0.000 description 117
- -1 Ascorbic acid stearates Chemical class 0.000 description 59
- 239000003921 oil Substances 0.000 description 36
- 235000019198 oils Nutrition 0.000 description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 239000003795 chemical substances by application Substances 0.000 description 22
- 239000012071 phase Substances 0.000 description 22
- 238000011282 treatment Methods 0.000 description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 19
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 19
- 238000009472 formulation Methods 0.000 description 19
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 18
- 239000000843 powder Substances 0.000 description 17
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 16
- 229920001577 copolymer Polymers 0.000 description 16
- 239000008213 purified water Substances 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 239000002304 perfume Substances 0.000 description 14
- 210000003491 skin Anatomy 0.000 description 14
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 13
- 229920001296 polysiloxane Polymers 0.000 description 13
- 239000006071 cream Substances 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 12
- 239000000049 pigment Substances 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 10
- 239000004166 Lanolin Substances 0.000 description 10
- 229940121363 anti-inflammatory agent Drugs 0.000 description 10
- 239000002260 anti-inflammatory agent Substances 0.000 description 10
- 239000008346 aqueous phase Substances 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 10
- 210000004209 hair Anatomy 0.000 description 10
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 10
- 235000019388 lanolin Nutrition 0.000 description 10
- 229940039717 lanolin Drugs 0.000 description 10
- 239000006210 lotion Substances 0.000 description 10
- 229940058015 1,3-butylene glycol Drugs 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 9
- 235000019437 butane-1,3-diol Nutrition 0.000 description 9
- 239000000839 emulsion Substances 0.000 description 9
- 241000233866 Fungi Species 0.000 description 8
- 235000021355 Stearic acid Nutrition 0.000 description 8
- 238000001816 cooling Methods 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 8
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 239000000344 soap Substances 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- 239000008117 stearic acid Substances 0.000 description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 229960000541 cetyl alcohol Drugs 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 6
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 6
- 239000004359 castor oil Substances 0.000 description 6
- 235000019438 castor oil Nutrition 0.000 description 6
- 229940000033 dermatological agent Drugs 0.000 description 6
- 239000003241 dermatological agent Substances 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- 229960001727 tretinoin Drugs 0.000 description 6
- 235000019165 vitamin E Nutrition 0.000 description 6
- 239000011709 vitamin E Substances 0.000 description 6
- 229940046009 vitamin E Drugs 0.000 description 6
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 5
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 5
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 5
- 206010040880 Skin irritation Diseases 0.000 description 5
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 229960005070 ascorbic acid Drugs 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 229940075507 glyceryl monostearate Drugs 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- 229940057995 liquid paraffin Drugs 0.000 description 5
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000002453 shampoo Substances 0.000 description 5
- 230000036556 skin irritation Effects 0.000 description 5
- 231100000475 skin irritation Toxicity 0.000 description 5
- 235000011076 sorbitan monostearate Nutrition 0.000 description 5
- 239000001587 sorbitan monostearate Substances 0.000 description 5
- 229940035048 sorbitan monostearate Drugs 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 4
- 235000013871 bee wax Nutrition 0.000 description 4
- 239000012166 beeswax Substances 0.000 description 4
- 239000000440 bentonite Substances 0.000 description 4
- 229910000278 bentonite Inorganic materials 0.000 description 4
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- 229940119217 chamomile extract Drugs 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000003779 hair growth Effects 0.000 description 4
- 150000002430 hydrocarbons Chemical group 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000693 micelle Substances 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 4
- 210000005253 yeast cell Anatomy 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- PBTPTBMYJPCXRQ-MGMRMFRLSA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O PBTPTBMYJPCXRQ-MGMRMFRLSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 3
- QAQJMLQRFWZOBN-UHFFFAOYSA-N 2-(3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)C1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 3
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 3
- 240000006891 Artemisia vulgaris Species 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 229960000458 allantoin Drugs 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 239000006229 carbon black Substances 0.000 description 3
- 229940008396 carrot extract Drugs 0.000 description 3
- 235000020221 chamomile extract Nutrition 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 235000020717 hawthorn extract Nutrition 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 229940072106 hydroxystearate Drugs 0.000 description 3
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 3
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 229940069445 licorice extract Drugs 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 208000035824 paresthesia Diseases 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical group CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- YICVJSOYNBZJAK-UHFFFAOYSA-N 14-methylpentadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C YICVJSOYNBZJAK-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- SAMYFBLRCRWESN-UHFFFAOYSA-N 16-methylheptadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C SAMYFBLRCRWESN-UHFFFAOYSA-N 0.000 description 2
- VRBHTEGUHVNKEA-UHFFFAOYSA-N 16-methylheptadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C VRBHTEGUHVNKEA-UHFFFAOYSA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N 2,3,4,5-tetrahydroxypentanal Chemical compound OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 2
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 2
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 101150065749 Churc1 gene Proteins 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 2
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 2
- 229920002079 Ellagic acid Polymers 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- 240000001972 Gardenia jasminoides Species 0.000 description 2
- 241001071795 Gentiana Species 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 150000000996 L-ascorbic acids Chemical class 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 235000017858 Laurus nobilis Nutrition 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 102100038239 Protein Churchill Human genes 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 239000004373 Pullulan Substances 0.000 description 2
- 229920001218 Pullulan Polymers 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- 241000543810 Sasa veitchii Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 244000223014 Syzygium aromaticum Species 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 2
- 244000125380 Terminalia tomentosa Species 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 description 2
- 240000002657 Thymus vulgaris Species 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 241001504592 Trachurus trachurus Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- YRXGUZPUZBCGST-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone Chemical compound OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 YRXGUZPUZBCGST-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 238000010306 acid treatment Methods 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 229940069521 aloe extract Drugs 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000010775 animal oil Substances 0.000 description 2
- 230000002280 anti-androgenic effect Effects 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000000051 antiandrogen Substances 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 235000019537 butterbur extract Nutrition 0.000 description 2
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- RAPXDXJBAYUBHI-UHFFFAOYSA-N decyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCCCCCC RAPXDXJBAYUBHI-UHFFFAOYSA-N 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 229960002852 ellagic acid Drugs 0.000 description 2
- 235000004132 ellagic acid Nutrition 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- MVLVMROFTAUDAG-UHFFFAOYSA-N ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC MVLVMROFTAUDAG-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 150000005165 hydroxybenzoic acids Chemical class 0.000 description 2
- 230000000774 hypoallergenic effect Effects 0.000 description 2
- AQYSYJUIMQTRMV-UHFFFAOYSA-N hypofluorous acid Chemical compound FO AQYSYJUIMQTRMV-UHFFFAOYSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- 229940078568 isocetyl myristate Drugs 0.000 description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 2
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 2
- 229940113915 isostearyl palmitate Drugs 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- 229940083980 lavender extract Drugs 0.000 description 2
- 235000020723 lavender extract Nutrition 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 229930013686 lignan Natural products 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- 150000005692 lignans Chemical class 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- 229960003632 minoxidil Drugs 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000019423 pullulan Nutrition 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 229960001755 resorcinol Drugs 0.000 description 2
- 235000020748 rosemary extract Nutrition 0.000 description 2
- 229940092258 rosemary extract Drugs 0.000 description 2
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 2
- 235000020752 sage extract Nutrition 0.000 description 2
- 229940112950 sage extract Drugs 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 231100000245 skin permeability Toxicity 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000020712 soy bean extract Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 229960005349 sulfur Drugs 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- 239000001585 thymus vulgaris Substances 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- 150000003625 trehaloses Chemical class 0.000 description 2
- 235000020240 turmeric extract Nutrition 0.000 description 2
- 239000008513 turmeric extract Substances 0.000 description 2
- 229940052016 turmeric extract Drugs 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- WFXHUBZUIFLWCV-UHFFFAOYSA-N (2,2-dimethyl-3-octanoyloxypropyl) octanoate Chemical compound CCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCC WFXHUBZUIFLWCV-UHFFFAOYSA-N 0.000 description 1
- DEQUKPCANKRTPZ-UHFFFAOYSA-N (2,3-dihydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O DEQUKPCANKRTPZ-UHFFFAOYSA-N 0.000 description 1
- BOCBOJPUWMTAJB-UHFFFAOYSA-N (2-butylphenyl) 2-hydroxybenzoate Chemical compound CCCCC1=CC=CC=C1OC(=O)C1=CC=CC=C1O BOCBOJPUWMTAJB-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- FBZQBGYPONNWCG-UHFFFAOYSA-N (4,5-dihydroxy-2,3-dimethoxyphenyl)-phenylmethanone Chemical compound COC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1OC FBZQBGYPONNWCG-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- HHEHWCIYDICHCG-ODZAUARKSA-N (z)-but-2-enedioic acid;methoxyethene Chemical compound COC=C.OC(=O)\C=C/C(O)=O HHEHWCIYDICHCG-ODZAUARKSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- KBKGPMDADJLBEM-UHFFFAOYSA-N 1-(4-pentylphenyl)ethanone Chemical compound CCCCCC1=CC=C(C(C)=O)C=C1 KBKGPMDADJLBEM-UHFFFAOYSA-N 0.000 description 1
- OOWQBDFWEXAXPB-UHFFFAOYSA-N 1-O-palmitylglycerol Chemical compound CCCCCCCCCCCCCCCCOCC(O)CO OOWQBDFWEXAXPB-UHFFFAOYSA-N 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- LALVCWMSKLEQMK-UHFFFAOYSA-N 1-phenyl-3-(4-propan-2-ylphenyl)propane-1,3-dione Chemical compound C1=CC(C(C)C)=CC=C1C(=O)CC(=O)C1=CC=CC=C1 LALVCWMSKLEQMK-UHFFFAOYSA-N 0.000 description 1
- GGZKJFGVSZKFLD-UHFFFAOYSA-N 1-prop-1-enyl-1h-imidazol-1-ium;chloride Chemical compound [Cl-].CC=CN1C=C[NH+]=C1 GGZKJFGVSZKFLD-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- OUZOBPPZPCBJAR-UHFFFAOYSA-N 14-methylpentadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C OUZOBPPZPCBJAR-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- WPIOBXGJZUSKGK-UHFFFAOYSA-N 16-methylheptadecyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C WPIOBXGJZUSKGK-UHFFFAOYSA-N 0.000 description 1
- MVUWRLHKGKEGSS-UHFFFAOYSA-N 16-methylheptadecyl octanoate Chemical compound CCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C MVUWRLHKGKEGSS-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- IZLVFLOBTPURLP-UHFFFAOYSA-N 2-Methoxy-4-nitrophenol Chemical compound COC1=CC([N+]([O-])=O)=CC=C1O IZLVFLOBTPURLP-UHFFFAOYSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- BHIZVZJETFVJMJ-UHFFFAOYSA-N 2-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)O BHIZVZJETFVJMJ-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- HTNFLUQQANUSLR-UHFFFAOYSA-N 2-octanoyloxyethyl octanoate Chemical compound CCCCCCCC(=O)OCCOC(=O)CCCCCCC HTNFLUQQANUSLR-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- XWTOOCUKCCXCPT-UHFFFAOYSA-N 2-phenyl-1h-benzimidazole;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC=CC=C1C1=NC2=CC=CC=C2N1 XWTOOCUKCCXCPT-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QZPSOSOOLFHYRR-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate Chemical compound OCCCOC(=O)C=C QZPSOSOOLFHYRR-UHFFFAOYSA-N 0.000 description 1
- LAIUFBWHERIJIH-UHFFFAOYSA-N 3MC7 Natural products CCCCC(C)CC LAIUFBWHERIJIH-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- WTIUUMRTSWJRFF-UHFFFAOYSA-N 4-(aminomethyl)benzenesulfonamide;dihydrate;trihydrochloride Chemical compound O.O.Cl.Cl.Cl.NCC1=CC=C(S(N)(=O)=O)C=C1.NCC1=CC=C(S(N)(=O)=O)C=C1.NCC1=CC=C(S(N)(=O)=O)C=C1 WTIUUMRTSWJRFF-UHFFFAOYSA-N 0.000 description 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- TZZAKSLHHIJRLL-UHFFFAOYSA-N 4-hydroxy-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1O TZZAKSLHHIJRLL-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical class OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
- PJJGZPJJTHBVMX-UHFFFAOYSA-N 5,7-Dihydroxyisoflavone Chemical compound C=1C(O)=CC(O)=C(C2=O)C=1OC=C2C1=CC=CC=C1 PJJGZPJJTHBVMX-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- YPIFGDQKSSMYHQ-UHFFFAOYSA-M 7,7-dimethyloctanoate Chemical compound CC(C)(C)CCCCCC([O-])=O YPIFGDQKSSMYHQ-UHFFFAOYSA-M 0.000 description 1
- ODMZDMMTKHXXKA-QXMHVHEDSA-N 8-methylnonyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCCCCCC(C)C ODMZDMMTKHXXKA-QXMHVHEDSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 239000001904 Arabinogalactan Substances 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 235000015701 Artemisia arbuscula Nutrition 0.000 description 1
- 235000002657 Artemisia tridentata Nutrition 0.000 description 1
- 239000004261 Ascorbyl stearate Substances 0.000 description 1
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 235000011960 Brassica ruvo Nutrition 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- FMOQNCWGCMYPQL-UHFFFAOYSA-N C(C)C(COC(CCN1C(NCC1=O)=O)=O)CCCC Chemical compound C(C)C(COC(CCN1C(NCC1=O)=O)=O)CCCC FMOQNCWGCMYPQL-UHFFFAOYSA-N 0.000 description 1
- AFWTZXXDGQBIKW-UHFFFAOYSA-N C14 surfactin Natural products CCCCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 AFWTZXXDGQBIKW-UHFFFAOYSA-N 0.000 description 1
- DFERZTIWCDQJHJ-AXDSSHIGSA-N CCOC(=O)C(C(C)=O)CNC(=O)[C@H](O)C(C)(C)CO Chemical compound CCOC(=O)C(C(C)=O)CNC(=O)[C@H](O)C(C)(C)CO DFERZTIWCDQJHJ-AXDSSHIGSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 1
- 241001515917 Chaetomium globosum Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001149956 Cladosporium herbarum Species 0.000 description 1
- 241000218158 Clematis Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical group CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- 239000003508 Dilauryl thiodipropionate Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241001632410 Eleutherococcus senticosus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 241000975394 Evechinus chloroticus Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
- ACEWLPOYLGNNHV-UHFFFAOYSA-N Ibuprofen piconol Chemical compound C1=CC(CC(C)C)=CC=C1C(C)C(=O)OCC1=CC=CC=N1 ACEWLPOYLGNNHV-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 235000016357 Mirtillo rosso Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- JYMTUMRIBSQSDZ-UHFFFAOYSA-N N',N'-dimethylethane-1,2-diamine octadecanoic acid Chemical class CN(C)CCN.CCCCCCCCCCCCCCCCCC(O)=O JYMTUMRIBSQSDZ-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 230000006181 N-acylation Effects 0.000 description 1
- 244000230712 Narcissus tazetta Species 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 241000183666 Nepsera aquatica Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- GWFGDXZQZYMSMJ-UHFFFAOYSA-N Octadecansaeure-heptadecylester Natural products CCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC GWFGDXZQZYMSMJ-UHFFFAOYSA-N 0.000 description 1
- RJECHNNFRHZQKU-UHFFFAOYSA-N Oelsaeurecholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCC=CCCCCCCCC)C2 RJECHNNFRHZQKU-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 241000490567 Pinctada Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- NKSOSPOXQKNIKJ-CLFAGFIQSA-N Polyoxyethylene dioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOC(=O)CCCCCCC\C=C/CCCCCCCC NKSOSPOXQKNIKJ-CLFAGFIQSA-N 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- YUGCAAVRZWBXEQ-UHFFFAOYSA-N Precholecalciferol Natural products C=1CCC2(C)C(C(C)CCCC(C)C)CCC2C=1C=CC1=C(C)CCC(O)C1 YUGCAAVRZWBXEQ-UHFFFAOYSA-N 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- YDBYJHTYSHBBAU-YFKPBYRVSA-N S-methyl-L-methioninate Chemical compound C[S+](C)CC[C@H](N)C([O-])=O YDBYJHTYSHBBAU-YFKPBYRVSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 239000009724 Salvia extract Substances 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 240000005499 Sasa Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 239000006087 Silane Coupling Agent Substances 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 206010040830 Skin discomfort Diseases 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 241000736285 Sphagnum Species 0.000 description 1
- 241001092387 Spiraea Species 0.000 description 1
- 235000020759 St. John’s wort extract Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 241001136508 Talaromyces luteus Species 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 241000736892 Thujopsis dolabrata Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000000377 Tussilago farfara Species 0.000 description 1
- 235000004869 Tussilago farfara Nutrition 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- PRLUQOOFPFWUKQ-KKTNLPSRSA-N [(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl] (z)-octadec-9-enoate Chemical compound C1C[C@@H]2[C@@]3(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C[C@@H]3CC[C@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@]21C PRLUQOOFPFWUKQ-KKTNLPSRSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 1
- JYKOABXVNYFDSR-UHFFFAOYSA-N [2-(8-hydroxyoctoxy)phenyl]-phenylmethanone Chemical compound OCCCCCCCCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 JYKOABXVNYFDSR-UHFFFAOYSA-N 0.000 description 1
- WUBKCBOQNXUQDU-UHFFFAOYSA-N [2-(dihydroxymethoxy)phenyl]-phenylmethanone Chemical compound OC(O)OC1=CC=CC=C1C(=O)C1=CC=CC=C1 WUBKCBOQNXUQDU-UHFFFAOYSA-N 0.000 description 1
- SVRHJWALMLOXMI-UHFFFAOYSA-N [2-(dihydroxymethoxy)phenyl]-phenylmethanone;sodium Chemical compound [Na].OC(O)OC1=CC=CC=C1C(=O)C1=CC=CC=C1 SVRHJWALMLOXMI-UHFFFAOYSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 229940124340 antiacne agent Drugs 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229940089116 arnica extract Drugs 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 235000019276 ascorbyl stearate Nutrition 0.000 description 1
- 235000019206 astragalus extract Nutrition 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 235000020739 avocado extract Nutrition 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 229940116224 behenate Drugs 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940092782 bentonite Drugs 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- WMNULTDOANGXRT-UHFFFAOYSA-N bis(2-ethylhexyl) butanedioate Chemical compound CCCCC(CC)COC(=O)CCC(=O)OCC(CC)CCCC WMNULTDOANGXRT-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- UTOVMEACOLCUCK-PLNGDYQASA-N butyl maleate Chemical compound CCCCOC(=O)\C=C/C(O)=O UTOVMEACOLCUCK-PLNGDYQASA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000008338 calamine lotion Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 229940048851 cetyl ricinoleate Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- XHRPOTDGOASDJS-UHFFFAOYSA-N cholesterol n-octadecanoate Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCCCC)C2 XHRPOTDGOASDJS-UHFFFAOYSA-N 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 1
- 229940073724 cholesteryl isostearate Drugs 0.000 description 1
- RJECHNNFRHZQKU-RMUVNZEASA-N cholesteryl oleate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C1 RJECHNNFRHZQKU-RMUVNZEASA-N 0.000 description 1
- XHRPOTDGOASDJS-XNTGVSEISA-N cholesteryl stearate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1 XHRPOTDGOASDJS-XNTGVSEISA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229920006026 co-polymeric resin Polymers 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- 229960000978 cyproterone acetate Drugs 0.000 description 1
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- BOUIEBMBWBCUPB-UHFFFAOYSA-N decyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCC BOUIEBMBWBCUPB-UHFFFAOYSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- 235000019304 dilauryl thiodipropionate Nutrition 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- MIMDHDXOBDPUQW-UHFFFAOYSA-N dioctyl decanedioate Chemical compound CCCCCCCCOC(=O)CCCCCCCCC(=O)OCCCCCCCC MIMDHDXOBDPUQW-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- VUPKGFBOKBGHFZ-UHFFFAOYSA-N dipropyl carbonate Chemical compound CCCOC(=O)OCCC VUPKGFBOKBGHFZ-UHFFFAOYSA-N 0.000 description 1
- 230000002554 disease preventive effect Effects 0.000 description 1
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 1
- IBQLPVCKRGGSCJ-UHFFFAOYSA-L disodium;1-tetradecoxytetradecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCCCOCCCCCCCCCCCCCC IBQLPVCKRGGSCJ-UHFFFAOYSA-L 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- CDIPRYKTRRRSEM-UHFFFAOYSA-M docosyl(trimethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C CDIPRYKTRRRSEM-UHFFFAOYSA-M 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- QQQMUBLXDAFBRH-UHFFFAOYSA-N dodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)O QQQMUBLXDAFBRH-UHFFFAOYSA-N 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229940012466 egg shell membrane Drugs 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000598 endocrine disruptor Substances 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- HBPVKGYQTMAQDM-UHFFFAOYSA-N ethene;2-hydroxybenzoic acid Chemical compound C=C.OC(=O)C1=CC=CC=C1O HBPVKGYQTMAQDM-UHFFFAOYSA-N 0.000 description 1
- FYUWIEKAVLOHSE-UHFFFAOYSA-N ethenyl acetate;1-ethenylpyrrolidin-2-one Chemical compound CC(=O)OC=C.C=CN1CCCC1=O FYUWIEKAVLOHSE-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 125000003709 fluoroalkyl group Chemical group 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 208000024386 fungal infectious disease Diseases 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 235000013761 grape skin extract Nutrition 0.000 description 1
- 229940065115 grapefruit extract Drugs 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- XAMHKORMKJIEFW-AYTKPMRMSA-N hexadecyl (z,12r)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC XAMHKORMKJIEFW-AYTKPMRMSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- QAKXLTNAJLFSQC-UHFFFAOYSA-N hexadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC QAKXLTNAJLFSQC-UHFFFAOYSA-N 0.000 description 1
- FPMPNVIMFPEKRN-UHFFFAOYSA-N hexyl 16-methylheptadecanoate Chemical compound CCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C FPMPNVIMFPEKRN-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000020721 horse chestnut extract Nutrition 0.000 description 1
- 238000003898 horticulture Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 235000019866 hydrogenated palm kernel oil Nutrition 0.000 description 1
- 239000010512 hydrogenated peanut oil Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229950005954 ibuprofen piconol Drugs 0.000 description 1
- 150000002462 imidazolines Chemical class 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 108010082754 iturin A Proteins 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229940105112 magnesium myristate Drugs 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- DMRBHZWQMKSQGR-UHFFFAOYSA-L magnesium;tetradecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O DMRBHZWQMKSQGR-UHFFFAOYSA-L 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229960003464 mefenamic acid Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- VLPIATFUUWWMKC-UHFFFAOYSA-N mexiletine Chemical compound CC(N)COC1=C(C)C=CC=C1C VLPIATFUUWWMKC-UHFFFAOYSA-N 0.000 description 1
- 229960001070 mexiletine hydrochloride Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229940059453 millet extract Drugs 0.000 description 1
- 229940105902 mint extract Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- NNSWOABHNWRKDR-UHFFFAOYSA-N n',n'-diethylethane-1,2-diamine;octadecanoic acid Chemical class CCN(CC)CCN.CCCCCCCCCCCCCCCCCC(O)=O NNSWOABHNWRKDR-UHFFFAOYSA-N 0.000 description 1
- RVRFYZGKUZFYAH-UHFFFAOYSA-N n',n'-dimethylpropane-1,3-diamine;octadecanoic acid Chemical class CN(C)CCCN.CCCCCCCCCCCCCCCCCC(O)=O RVRFYZGKUZFYAH-UHFFFAOYSA-N 0.000 description 1
- BPXGKRUSMCVZAF-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)decanamide Chemical compound CCCCCCCCCC(=O)N(CCO)CCO BPXGKRUSMCVZAF-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JYOZEBNARYTWFK-UHFFFAOYSA-N n-octylprop-2-enamide;prop-2-enoic acid Chemical compound OC(=O)C=C.CCCCCCCCNC(=O)C=C JYOZEBNARYTWFK-UHFFFAOYSA-N 0.000 description 1
- 229960003808 nadifloxacin Drugs 0.000 description 1
- JYJTVFIEFKZWCJ-UHFFFAOYSA-N nadifloxacin Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)CCC3=C1N1CCC(O)CC1 JYJTVFIEFKZWCJ-UHFFFAOYSA-N 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- RGOVYLWUIBMPGK-UHFFFAOYSA-N nonanoic acid vanillylamide Natural products CCCCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 RGOVYLWUIBMPGK-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- YPMOZWCBANATQH-UHFFFAOYSA-N octyl 7-methyloctanoate Chemical compound CCCCCCCCOC(=O)CCCCCC(C)C YPMOZWCBANATQH-UHFFFAOYSA-N 0.000 description 1
- 239000000574 octyl gallate Substances 0.000 description 1
- 235000010387 octyl gallate Nutrition 0.000 description 1
- NRPKURNSADTHLJ-UHFFFAOYSA-N octyl gallate Chemical compound CCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1 NRPKURNSADTHLJ-UHFFFAOYSA-N 0.000 description 1
- IIGMITQLXAGZTL-UHFFFAOYSA-N octyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC IIGMITQLXAGZTL-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940048862 octyldodecyl neopentanoate Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 229940124641 pain reliever Drugs 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 229940117336 parsley extract Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- HMNQKNBOXPSFDQ-UHFFFAOYSA-N pentadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCC(O)=O HMNQKNBOXPSFDQ-UHFFFAOYSA-N 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 235000020737 peppermint extract Nutrition 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000010702 perfluoropolyether Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- LYKRPDCJKSXAHS-UHFFFAOYSA-N phenyl-(2,3,4,5-tetrahydroxyphenyl)methanone Chemical compound OC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1O LYKRPDCJKSXAHS-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229940067631 phospholipid Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000003032 phytopathogenic effect Effects 0.000 description 1
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 1
- 229940033329 phytosphingosine Drugs 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 229940081510 piroctone olamine Drugs 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-M pivalate Chemical compound CC(C)(C)C([O-])=O IUGYQRQAERSCNH-UHFFFAOYSA-M 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 229940116422 propylene glycol dicaprate Drugs 0.000 description 1
- 229940026235 propylene glycol monolaurate Drugs 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 239000001944 prunus armeniaca kernel oil Substances 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical class O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 150000004609 retinol derivatives Chemical class 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 229940119485 safflower extract Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000008257 shaving cream Substances 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940001482 sodium sulfite Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- 229940099416 st. john's wort extract Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 235000001508 sulfur Nutrition 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- NJGWOFRZMQRKHT-UHFFFAOYSA-N surfactin Natural products CC(C)CCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-UHFFFAOYSA-N 0.000 description 1
- NJGWOFRZMQRKHT-WGVNQGGSSA-N surfactin C Chemical compound CC(C)CCCCCCCCC[C@@H]1CC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-WGVNQGGSSA-N 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 239000001430 tilia cordata extract Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 108010021724 tonin Proteins 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- QPQANCNBWQXGTQ-UHFFFAOYSA-N trihydroxy(trimethylsilylperoxy)silane Chemical compound C[Si](C)(C)OO[Si](O)(O)O QPQANCNBWQXGTQ-UHFFFAOYSA-N 0.000 description 1
- KNXVOGGZOFOROK-UHFFFAOYSA-N trimagnesium;dioxido(oxo)silane;hydroxy-oxido-oxosilane Chemical compound [Mg+2].[Mg+2].[Mg+2].O[Si]([O-])=O.O[Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O KNXVOGGZOFOROK-UHFFFAOYSA-N 0.000 description 1
- SZEMGTQCPRNXEG-UHFFFAOYSA-M trimethyl(octadecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C SZEMGTQCPRNXEG-UHFFFAOYSA-M 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristoyl-sn-glycerol Natural products CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- APVVRLGIFCYZHJ-UHFFFAOYSA-N trioctyl 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCC)CC(=O)OCCCCCCCC APVVRLGIFCYZHJ-UHFFFAOYSA-N 0.000 description 1
- COXJMKGEQAWXNP-UHFFFAOYSA-N tris(14-methylpentadecyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CC(C)CCCCCCCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCCCCCCCC(C)C)CC(=O)OCCCCCCCCCCCCCC(C)C COXJMKGEQAWXNP-UHFFFAOYSA-N 0.000 description 1
- RHNXTZDKMRCKKT-UHFFFAOYSA-N tris(6-methylheptyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CC(C)CCCCCOC(=O)CC(O)(C(=O)OCCCCCC(C)C)CC(=O)OCCCCCC(C)C RHNXTZDKMRCKKT-UHFFFAOYSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- GAAKLDANOSASAM-UHFFFAOYSA-N undec-10-enoic acid;zinc Chemical compound [Zn].OC(=O)CCCCCCCCC=C GAAKLDANOSASAM-UHFFFAOYSA-N 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 229940098697 zinc laurate Drugs 0.000 description 1
- 229940105125 zinc myristate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- 229940012185 zinc palmitate Drugs 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- 229940118257 zinc undecylenate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
- GPYYEEJOMCKTPR-UHFFFAOYSA-L zinc;dodecanoate Chemical compound [Zn+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O GPYYEEJOMCKTPR-UHFFFAOYSA-L 0.000 description 1
- GJAPSKMAVXDBIU-UHFFFAOYSA-L zinc;hexadecanoate Chemical compound [Zn+2].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O GJAPSKMAVXDBIU-UHFFFAOYSA-L 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
- GBFLQPIIIRJQLU-UHFFFAOYSA-L zinc;tetradecanoate Chemical compound [Zn+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O GBFLQPIIIRJQLU-UHFFFAOYSA-L 0.000 description 1
- 239000001243 zingiber officinale rosc. root absolute Substances 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、化粧品に用いるこ
とのできる安全性が高いアイチュリン系ペプチドを含む
抗菌性化粧料組成物に関する。TECHNICAL FIELD The present invention relates to an antibacterial cosmetic composition containing a highly safe iturin peptide that can be used in cosmetics.
【0002】[0002]
【従来の技術】従来、化粧品は使用時毎に、直接に、手
など人体の一部と接触し、さらに化粧品容器の開封によ
って空気などを介して外界環境とも触れるために、多種
多様な微生物、いわゆる雑菌が製品に混入して、その品
質を著しく低下せしめる本質的な危険性を孕んでいる。
このため全ての化粧品には、品質を維持する目的で、フ
ェノール類、ヒドロキシ安息香酸エステル類などの低毒
性の防菌防カビ剤が配合されている。これらの他に、水
銀が特殊な用途に使用されることもある。2. Description of the Related Art Conventionally, cosmetics come into direct contact with a part of the human body such as hands each time they are used, and further, when the cosmetics container is opened, the cosmetics also come into contact with the external environment via air, etc. There is an inherent risk that so-called bacteria will be mixed into the product and its quality will be significantly reduced.
Therefore, in order to maintain quality, all cosmetics are blended with low toxicity antibacterial and antifungal agents such as phenols and hydroxybenzoic acid esters. In addition to these, mercury may be used for special purposes.
【0003】このうち、例えば、フェノール類は防菌防
カビ力が弱いため、十分な効果を得るためには、より高
濃度で使用することが求められるが、高濃度のフェノー
ル類は共存するタンパク質を変性させてしまうため、現
実的に使用できない。[0003] Of these, for example, phenols have weak antibacterial and fungicidal activity, and therefore, in order to obtain a sufficient effect, it is required to use a higher concentration, but a high concentration of phenols is a coexisting protein. Since it degenerates, it cannot be practically used.
【0004】他方、ヒドロキシ安息香酸エステル類、い
わゆるパラベンは、真菌類に対して静菌作用があるもの
の、グラム陰性菌には効果がない。また、パラベン類は
水に対して溶解度が低く、例えば、低温で使用する場合
には、必要十分量が溶解できないため、満足できる効果
が期待できない欠点がある。さらに、パラベン類につい
ては、最近、いわゆる環境ホルモンの疑いが一部で持た
れており、必ずしも安全であるとも言えなくなってきて
いる。On the other hand, hydroxybenzoic acid esters, so-called parabens, have a bacteriostatic action against fungi, but have no effect on Gram-negative bacteria. In addition, parabens have low solubility in water, for example, when used at low temperatures, they cannot be dissolved in a necessary and sufficient amount, so that a satisfactory effect cannot be expected. Furthermore, with regard to parabens, recently, there is some suspicion that they are so-called endocrine disrupters, and it cannot be said that they are necessarily safe.
【0005】また、例えば、パラベン類を化粧品に添加
していても、微生物はこれらに対して抵抗性を獲得して
しまうため、防除効果が急速に低下し、ついには効力を
失ってしまうという根本的な問題がある。[0005] Further, for example, even if parabens are added to cosmetics, microorganisms acquire resistance to them, so that the control effect is rapidly reduced, and finally the efficacy is lost. Problem.
【0006】近年、化粧料は低刺激性のものが強く要望
されており、無着色・無香料やノンアルコールの化粧料
が開発され、市場を席捲している。しかしながら、皮膚
刺激性に関しては、パラベンをはじめ防腐剤による刺激
が大きな要因を占めており、防腐剤を使わない化粧料も
検討されているが、この場合、雑菌の繁殖を抑えるため
に化粧料を低温保管するなどの処置が必要となり、使用
に際し極めて不便なものとなる。In recent years, there has been a strong demand for cosmetics that are hypoallergenic, and non-colored, fragrance-free and non-alcoholic cosmetics have been developed and dominated the market. However, regarding skin irritation, irritation by preservatives such as parabens is a major factor, and cosmetics that do not use preservatives are also being investigated, but in this case, in order to suppress the propagation of various bacteria, cosmetics should be used. It requires a treatment such as storage at low temperature, which makes it extremely inconvenient to use.
【0007】このような中、本発明で使用されるアイチ
ュリン(Iturin)系ペプチドは、真菌類に対して強力な
抗生作用を有していることがわかっており、これを微生
物汚染の防除に利用する方法が報告されている。例え
ば、M. A. Klichi(Mycopathologia 127:123-127,1994)
らは、アイチュリンがカビ類に対して強い抗生作用を持
つと同時に、動物に対して高い安全性を示すことから、
各種穀物の貯蔵時に発生するカビによる微生物汚染につ
いてアイチュリンの防除効果を測定している。その結
果、アイチュリンを50〜100ppmの濃度で使用すれ
ば、カビの発生を著しく抑制することができると報告し
ている。Under these circumstances, iturin peptides used in the present invention are known to have a strong antibacterial action against fungi, and they are used for controlling microbial contamination. How to do is reported. For example, MA Klichi (Mycopathologia 127: 123-127,1994)
Etiulin has a strong antibacterial action against fungi, and at the same time shows high safety against animals,
The control effect of iturin on microbial contamination by molds generated during storage of various grains is measured. As a result, it is reported that the use of iturin at a concentration of 50 to 100 ppm can significantly suppress the generation of mold.
【0008】具体的にアイチュリンが示す殺菌力を利用
した技術が、例えば、農業園芸分野における植物病原菌
の生育抑制に適用する方法について特開昭59−212
416号公報、特開昭61−289005号公報、特開
昭61−289898号公報に開示されている。また特
開平7−143897号公報には、アイチュリンを深在
性真菌症の予防乃至治療に用いる方法が開示されてい
る。これによれば、アイチュリンを経口投与或いは皮
下、筋肉内または静脈内に注射する非経口投与により用
いて、各種真菌感染症の治療を行うというものである。A method in which a technique utilizing the bactericidal activity of iturin is applied to, for example, suppressing the growth of phytopathogenic fungi in the field of agriculture and horticulture is disclosed in JP-A-59-212.
Nos. 416, 61-289005, and 61-289898. Further, Japanese Patent Application Laid-Open No. 7-143897 discloses a method of using iturin for the prevention or treatment of deep-seated mycosis. According to this, various fungal infections are treated by oral administration of iturin or parenteral administration of subcutaneous, intramuscular or intravenous injection.
【0009】この際に問題となるアイチュリンの毒性に
ついては、細胞毒性試験においては1〜0.5mg/mL以下
の濃度では細胞毒性が認められず、、急性毒性試験にお
いてもLD50が2,000mg/Kg以上と、アイチュリンの
安全性が高いことが示されている。Regarding the toxicity of iturin, which is a problem in this case, no cytotoxicity was observed at a concentration of 1 to 0.5 mg / mL or less in the cytotoxicity test, and the LD 50 was 2,000 mg in the acute toxicity test. It is shown that the safety of iturin is high with / Kg or more.
【0010】[0010]
【発明が解決しようとする課題】本発明者らは、広い抗
菌スペクトルと強い殺菌力を併せ持ち、なお且つヒトに
対する安全性が極めて高く、安心して反復使用できる天
然系抗菌物質について鋭意検討を重ねてきた。その結
果、アイチュリン系ペプチドが優れた抗菌性能を有して
おり、さらに環境中で容易に生分解され、且つヒトや動
物に対して無害であり、化粧料組成物として顕著な性能
を発揮することを見出し、本発明を完成するに至ったも
のである。DISCLOSURE OF THE INVENTION The present inventors have conducted extensive studies on a natural antibacterial substance which has a broad antibacterial spectrum and a strong bactericidal activity, and is extremely safe for humans and can be repeatedly used with peace of mind. It was As a result, iturin-based peptides have excellent antibacterial properties, are easily biodegradable in the environment, and are harmless to humans and animals, and exhibit outstanding properties as cosmetic compositions. The present invention has been completed and the present invention has been completed.
【0011】[0011]
【課題を解決するための手段】本発明は、抗菌性を有す
るアイチュリンを化粧品に配合することによって、化粧
品の抗菌性を増強し、その保存安定性を著しく高めるこ
とができる抗菌性化粧料組成物に関する。The present invention provides an antibacterial cosmetic composition capable of enhancing the antibacterial property of cosmetics and remarkably enhancing the storage stability thereof by incorporating iturin having antibacterial properties into cosmetics. Regarding
【0012】すなわち、本発明は以下の事項に関する。
(1)アイチュリン系ペプチドを有効成分とする抗菌性
化粧料組成物。
(2)アイチュリン系ペプチドが一般式(1)で示され
る化合物である上記(1)に記載の抗菌性化粧料組成
物。That is, the present invention relates to the following items. (1) An antibacterial cosmetic composition containing an iturin peptide as an active ingredient. (2) The antibacterial cosmetic composition according to (1) above, wherein the iturin peptide is a compound represented by the general formula (1).
【0013】[0013]
【化2】
(式(1)中、Rは炭素鎖3〜10の直鎖又は分岐上の
アルキル基を表す。)[Chemical 2] (In the formula (1), R represents a linear or branched alkyl group having 3 to 10 carbon chains.)
【0014】(3)脂溶性ビタミンまたはその誘導体を
含有することを特徴とする上記(1)または(2)に記
載の抗菌性化粧料組成物。
(4)上記(1)ないし(3)のいずれかに記載の抗菌
性化粧料組成物を含有する化粧料。
(5)上記(1)ないし(3)のいずれかに記載の抗菌
性化粧料組成物を含有する皮膚用剤。
(6)アクネ、アトピー性皮膚炎の予防または治療剤で
ある上記(5)に記載の皮膚用剤。(3) The antibacterial cosmetic composition according to the above (1) or (2), which contains a fat-soluble vitamin or a derivative thereof. (4) A cosmetic containing the antibacterial cosmetic composition according to any one of (1) to (3). (5) A skin agent containing the antibacterial cosmetic composition according to any one of (1) to (3). (6) The skin preparation according to (5) above, which is a prophylactic or therapeutic agent for acne and atopic dermatitis.
【0015】[0015]
【発明の実施の形態】本発明で使用されるアイチュリン
系ペプチドは、特に限定されないが、下記式(1)BEST MODE FOR CARRYING OUT THE INVENTION The iturin-based peptide used in the present invention is not particularly limited, but is represented by the following formula (1):
【0016】[0016]
【化3】 [Chemical 3]
【0017】(式(1)中、Rは炭素鎖3〜10の直鎖
又は分岐上のアルキル基を表す。)で示される化合物が
好適である。本発明の効果を損なわない範囲内で、構造
変化、収縮されたものも使用できることはいうまでもな
い。A compound represented by the formula (1) wherein R represents a linear or branched alkyl group having 3 to 10 carbon chains is preferable. Needless to say, those having a structural change or contraction can be used as long as the effects of the present invention are not impaired.
【0018】式中、Rは炭素鎖3〜10の直鎖又は分岐
上のアルキル基であり、好ましくは、(CH3)CHC
H2、(CH3)CHCH2CH2、(CH3)CHCH2C
H2CH2、CH3CH2CH2、CH3CH2CH(C
H3)、CH3CH2CH2CH2CH2、CH3CH(C
H3)CH2CH2、CH3CH2CH2CH2CH2CH2等
が挙げられるIn the formula, R is a linear or branched alkyl group having 3 to 10 carbon chains, preferably (CH 3 ) CHC
H 2 , (CH 3 ) CHCH 2 CH 2 , (CH 3 ) CHCH 2 C
H 2 CH 2 , CH 3 CH 2 CH 2 , CH 3 CH 2 CH (C
H 3), CH 3 CH 2 CH 2 CH 2 CH 2, CH 3 CH (C
H 3 ) CH 2 CH 2 , CH 3 CH 2 CH 2 CH 2 CH 2 CH 2 and the like.
【0019】アイチュリンの作用機作は細胞膜に浸透し
て孔をつくることにあり、この際、アイチュリンは細胞
膜成分とと疎水的に会合することがわかっている(R. Ma
get-Dana et al(Toxicoloogy 87,151-174,1994), C.
Latoud et al(Can. J. Microbiol 36;384-389,1990))。The mechanism of action of iturin is to penetrate into the cell membrane to form pores, in which iturin is known to associate hydrophobically with cell membrane components (R. Ma.
get-Dana et al (Toxicoloogy 87,151-174,1994), C.
Latoud et al (Can. J. Microbiol 36; 384-389, 1990)).
【0020】一方、化粧品にも多種多様な疎水性分子が
その目的に合わせて配合されており、化粧品として求め
られる機能を担っていることは言うまでもない。アイチ
ュリンはこのような疎水性成分とも有機的に会合でき、
それらの皮膚細胞への接近や浸透を補助する性質が必然
的に備わっている。On the other hand, it goes without saying that a wide variety of hydrophobic molecules are also incorporated into cosmetics in accordance with their purposes, and they fulfill the functions required for cosmetics. Iturin can also organically associate with such hydrophobic components,
Inevitably, it has the property of assisting their access to and penetration of skin cells.
【0021】そのような疎水性成分の例としては、例え
ば、L−アスコルビン酸パルミチン酸エステルや、L−
アスコルビン酸ステアリン酸エステルのように、長い炭
化水素鎖を持つビタミン類が挙げられるが、これらは細
胞膜や細胞質に存在する酵素(エステラーゼ)の作用を
受け、その炭化水素鎖が修飾・消化された後に、アスコ
ルビン酸に変換されて生理活性作用を発現することにな
るので、化粧品に用いれば、ヒトの必須ビタミンを補給
できる上、その抗酸化作用をはじめとして有用な機能を
もたらすことができる。さらにアスコルビン酸誘導体に
限らず、脂溶性ビタミンはもちろんのこと、水溶性ビタ
ミンについても、前述のアスコルビン酸誘導体のように
長い炭化水素鎖を有する安定化ビタミンについても同様
の効果をもたらすことが期待できる。Examples of such hydrophobic components include L-ascorbic acid palmitate and L-ascorbic acid palmitate.
Ascorbic acid stearates, vitamins with a long hydrocarbon chain can be mentioned, but these are affected by the enzyme (esterase) existing in the cell membrane and cytoplasm, and after the hydrocarbon chain is modified and digested, Since it is converted into ascorbic acid to exert a physiologically active action, it can be used in cosmetics to supplement human essential vitamins and to bring about useful functions such as its antioxidant action. Furthermore, not only ascorbic acid derivatives but also fat-soluble vitamins, water-soluble vitamins, and stabilized vitamins having a long hydrocarbon chain like the above-mentioned ascorbic acid derivatives can be expected to bring similar effects. .
【0022】このように本発明は、生理作用を有する有
機化合物の誘導体を用いることにより、単に化粧品の安
定化剤としての抗菌作用の他に、ヒトに対して有益な機
能を招来することも可能である。また、これら誘導体に
限らず、アイチュリンが疎水的に会合してつくるミセル
構造の中に、それら有益な成分を包み込むこともできる
ので、同様な効果が期待できる。As described above, according to the present invention, by using a derivative of an organic compound having a physiological action, in addition to the antibacterial action as a stabilizer for cosmetics, it is possible to bring about a beneficial function for humans. Is. Further, not only these derivatives, but also beneficial compounds can be wrapped in a micelle structure formed by iturin hydrophobically associated with each other, and the same effect can be expected.
【0023】このようにアイチュリンの細胞膜浸透作用
並びにミセルの形成によって、結果的に皮膚浸透が促進
されて、その生理作用が期待される化合物としては、例
えば、ビタミンA、プロビタミンA、ビタミンD、プロ
ビタミンD、ビタミンE、ビタミンKなどの脂溶性ビタ
ミン、チアミン、リボフラビン、ナイアシン、ビタミン
B6群、パントテン酸、ビオチン、myo-イノシトール、
コリン、ホラシン、ビタミンB12、ビタミンCのような
水溶性ビタミン及びその誘導体、ユビキノン、リポ酸、
ビタミンF、ビタミンB13、ビタミンBT、p-アミノ安
息香酸、ビタミンP、ビタミンUなどのビタミン様作用
因子及びその誘導体が挙げられる。As described above, iturin cell membrane permeation action and micelle formation result in accelerated skin permeation, and compounds expected to have physiological effects include, for example, vitamin A, provitamin A, vitamin D, Fat-soluble vitamins such as provitamin D, vitamin E, and vitamin K, thiamine, riboflavin, niacin, vitamin B 6 group, pantothenic acid, biotin, myo-inositol,
Water-soluble vitamins such as choline, holacin, vitamin B 12 , vitamin C and their derivatives, ubiquinone, lipoic acid,
Vitamin-like acting factors such as vitamin F, vitamin B 13 , vitamin B T , p-aminobenzoic acid, vitamin P and vitamin U and derivatives thereof can be mentioned.
【0024】本発明の化粧料はアイチュリンを必須成分
とするが、加えて、本発明の効果を損なわない範囲で、
化粧料に用いられる成分、例えば、化粧品原料基準第二
版注解、日本公定書教会編、1984(薬事日報社)、
化粧品原料基準外成分規格、厚生省薬務局審査課監修、
1993(薬事日報社)、化粧品原料基準外成分規格追
補、厚生省薬務局審査課監修、1993(薬事日報
社)、化粧品種別許可基準、厚生省薬務局審査課監修、
1993(薬事日報社)、および化粧品原料辞典、平成
3年(日光ケミカルズ)等、に記載されている成分を配
合することができる。The cosmetic of the present invention contains iturin as an essential component, but in addition, within a range not impairing the effects of the present invention,
Ingredients used in cosmetics, for example, 2nd edition commentary on cosmetic raw material standards, edited by The Church of Japan Official Book, 1984 (Yakuji Nipposha),
Non-standard ingredients for cosmetics, supervised by Ministry of Health, Labor and Welfare Pharmaceutical Affairs Bureau Examination Division,
1993 (Pharmaceutical Daily), supplement of non-standard ingredients for cosmetics, supervision by the Ministry of Health, Labor and Welfare Pharmaceutical Affairs Bureau examination section, 1993 (Pharmaceutical Affairs Daily), approval criteria by makeup type, Ministry of Health, Labor and Welfare Administration Division examination section,
Ingredients described in 1993 (Yakuji Nippo Co., Ltd.), Cosmetic Raw Materials Dictionary, 1991 (Nikko Chemicals), etc. can be added.
【0025】例えば、油分、高級アルコール、脂肪酸、
紫外線吸収剤、粉体、顔料、界面活性剤、多価アルコー
ル・糖、高分子、生理活性成分、溶媒、酸化防止剤、香
料、防腐剤等、添加可能な材料例を以下に羅列するが、
むろん本発明はこれらの例に限定されるものではない。For example, oil, higher alcohol, fatty acid,
Examples of materials that can be added, such as ultraviolet absorbers, powders, pigments, surfactants, polyhydric alcohols / sugars, polymers, physiologically active ingredients, solvents, antioxidants, fragrances and preservatives, are listed below.
Of course, the invention is not limited to these examples.
【0026】(1)油分の例
エステル系の油相成分:トリ2−エチルヘキサン酸グリ
セリル、2−エチルヘキサン酸セチル、ミリスチン酸イ
ソプロピル、ミリスチン酸ブチル、パルミチン酸イソプ
ロピル、ステアリン酸エチル、パルミチン酸オクチル、
イソステアリン酸イソセチル、ステアリン酸ブチル、ミ
リスチン酸ブチル、リノール酸エチル、(1) Example of Oil Ester-based oil phase components: glyceryl tri-2-ethylhexanoate, cetyl 2-ethylhexanoate, isopropyl myristate, butyl myristate, isopropyl palmitate, ethyl stearate, octyl palmitate ,
Isocetyl isostearate, butyl stearate, butyl myristate, ethyl linoleate,
【0027】リノール酸イソプロピル、オレイン酸エチ
ル、ミリスチン酸イソセチル、ミリスチン酸イソステア
リル、パルミチン酸イソステアリル、ミリスチン酸オク
チルドデシル、イソステアリン酸イソセチル、セバシン
酸ジエチル、アジピン酸ジイソプロピル、ネオペンタン
酸イソアラキル、トリ(カプリル・カプリン酸)グリセ
リル、トリ2−エチルヘキサン酸トリメチロールプロパ
ン、トリイソステアリン酸トリメチロールプロパン、テ
トラ2−エチルヘキサン酸ペンタエリスリトール、カプ
リル酸セチル、ラウリン酸デシル、ラウリン酸ヘキシ
ル、ミリスチン酸デシル、ミリスチン酸ミリスチル、ミ
リスチン酸セチル、ステアリン酸ステアリル、オレイン
酸デシル、リシノレイン酸セチル、ラウリン酸イソステ
アリル、ミリスチン酸イソトリデシル、ミリスチン酸イ
ソセチル、ミリスチン酸イソステアリル、パルミチン酸
イソセチル、パルミチン酸イソステアリル、ステアリン
酸オクチル、ステアリン酸イソセチル、オレイン酸イソ
デシル、オレイン酸オクチルドデシル、リノール酸オク
チルドデシル、イソステアリン酸イソプロピル、2−エ
チルヘキサン酸セトステアリル、2−エチルヘキサン酸
ステアリル、イソステアリン酸ヘキシル、ジオクタン酸
エチレングリコール、ジオレイン酸エチレングリコー
ル、ジカプリン酸プロピレングリコール、ジ(カプリ
ル、カプリン酸)プロピレングリコール、ジカプリル酸
プロピレングリコール、ジカプリン酸ネオペンチルグリ
コール、ジオクタン酸ネオペンチルグリコール、トリカ
プリル酸グリセリル、トリウンデシル酸グリセリル、ト
リイソパルミチン酸グリセリル、トリイソステアリン酸
グリセリル、ネオペンタン酸オクチルドデシル、オクタ
ン酸イソステアリル、イソノナン酸オクチル、ネオデカ
ン酸ヘキシルデシル、ネオデカン酸オクチルドデシル、
イソステアリン酸イソセチル、イソステアリン酸イソス
テアリル、イソステアリン酸オクチルデシル、ポリグリ
セリンオレイン酸エステル、ポリグリセリンイソステア
リン酸エステル、炭酸ジプロピル、炭酸ジアルキル(C
12−18)、クエン酸トリイソセチル、クエン酸トリイソ
アラキル、クエン酸トリイソオクチル、乳酸ラウリル、
乳酸ミリスチル、乳酸セチル、乳酸オクチルデシル、ク
エン酸トリエチル、クエン酸アセチルトリエチル、クエ
ン酸アセチルトリブチル、クエン酸トリオクチル、リン
ゴ酸ジイソステアリル、ヒドロキシステアリン酸2−エ
チルヘキシル、コハク酸ジ2−エチルヘキシル、アジピ
ン酸ジイソブチル、セバシン酸ジイソプロピル、セバシ
ン酸ジオクチル、ステアリン酸コレステリル、イソステ
アリン酸コレステリル、ヒドロキシステアリン酸コレス
テリル、オレイン酸コレステリル、オレイン酸ジヒドロ
コレステリル、イソステアリン酸フィトステリル、オレ
イン酸フィトステリル、12−ステアロイルヒドロキシ
ステアリン酸イソセチル、12−ステアロイルヒドロキ
システアリン酸ステアリル、12−ステアロイルヒドロ
キシステアリン酸イソステアリル等が挙げられる。Isopropyl linoleate, ethyl oleate, isocetyl myristate, isostearyl myristate, isostearyl palmitate, octyldodecyl myristate, isocetyl isostearate, diethyl sebacate, diisopropyl adipate, isoarachial neopentanoate, tri (capryl. Capric acid) glyceryl, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triisostearate, pentaerythritol tetra-2-ethylhexanoate, cetyl caprylate, decyl laurate, hexyl laurate, decyl myristate, myristyl myristate. , Cetyl myristate, stearyl stearate, decyl oleate, cetyl ricinoleate, isostearyl laurate, myristin Isotridecyl, isocetyl myristate, isostearyl myristate, isocetyl palmitate, isostearyl palmitate, octyl stearate, isocetyl stearate, isodecyl oleate, octyldodecyl oleate, octyldodecyl linoleate, isopropyl isostearate, 2-ethylhexane Acid cetostearyl, 2-ethylhexanoic acid stearyl, hexyl isostearate, ethylene glycol dioctanoate, ethylene glycol dioleate, propylene glycol dicaprate, propylene glycol di (capryl, caprate) propylene glycol dicaprylate, neopentyl glycol dicaprate , Neopentyl glycol dioctanoate, glyceryl tricaprylate, triundecyl acrylate Seryl, triisopalmitate, glyceryl triisostearate, glyceryl octyldodecyl neopentanoate, isostearyl octanoate, octyl isononanoate, neodecanoic acid hexyl decyl, neodecanoate octyldodecyl,
Isocetyl isostearate, isostearyl isostearate, octyldecyl isostearate, polyglycerin oleate, polyglycerin isostearate, dipropyl carbonate, dialkyl carbonate (C
12-18), triisocetyl citrate, triisoaralkyl citrate, triisooctyl citrate, lauryl lactate,
Myristyl lactate, cetyl lactate, octyldecyl lactate, triethyl citrate, acetyltriethyl citrate, acetyltributyl citrate, trioctyl citrate, diisostearyl malate, 2-ethylhexyl hydroxystearate, di2-ethylhexyl succinate, adipic acid Diisobutyl, diisopropyl sebacate, dioctyl sebacate, cholesteryl stearate, cholesteryl isostearate, cholesteryl hydroxystearate, cholesteryl oleate, dihydrocholesteryl oleate, phytosteryl isostearate, phytosteryl oleate, 12-stearoyl isosetyl hydroxystearate, 12- Stearyl stearoyl hydroxystearate, 12-stearoyl hydroxystearate Sosuteariru, and the like.
【0028】炭化水素系の油相成分:スクワラン、流動
パラフィン、α−オレフィンオリゴマー、イソパラフィ
ン、セレシン、パラフィン、流動イソパラフィン、ポリ
ブテン、マイクロクリスタリンワックス、ワセリン等が
挙げられる。Hydrocarbon-based oil phase components: squalane, liquid paraffin, α-olefin oligomer, isoparaffin, ceresin, paraffin, liquid isoparaffin, polybutene, microcrystalline wax, petrolatum and the like.
【0029】動植物油とその硬化油、及び天然由来のロ
ウ:牛脂、硬化牛脂、豚脂、硬化豚脂、馬油、硬化馬
油、ミンク油、オレンジラフィー油、魚油、硬化魚油、
卵黄油等の動物油及びその硬化油、アボカド油、アーモ
ンド油、オリーブ油、カカオ油、杏仁油、ココナッツ
油、ゴマ油、小麦胚芽油、コメ胚芽油、コメヌカ油、サ
フラワー油、シアバター、大豆油、月見草油、ツバキ
油、トウモロコシ油、ナタネ油、硬化ナタネ油、パーム
核油、硬化パーム核油、パーム油、硬化パーム油、ピー
ナッツ油、硬化ピーナッツ油、ヒマシ油、硬化ヒマシ
油、ヒマワリ油、ブドウ種子油、ホホバ油、硬化ホホバ
油、マカデミアナッツ油、メドホーム油、綿実油、硬化
綿実油、ヤシ油、硬化ヤシ油等の植物油及びその硬化
油、ミツロウ、高酸価ミツロウ、ラノリン、還元ラノリ
ン、液状ラノリン、カルナバロウ、モンタンロウ等のロ
ウ等が挙げられる。Animal and vegetable oils and hydrogenated oils thereof and naturally occurring waxes: beef tallow, hydrogenated beef tallow, lard, hydrogenated lard, horse oil, hydrogenated horse oil, mink oil, orange laffy oil, fish oil, hydrogenated fish oil,
Animal oils such as egg yolk oil and hydrogenated oils thereof, avocado oil, almond oil, olive oil, cacao oil, apricot kernel oil, coconut oil, sesame oil, wheat germ oil, rice germ oil, rice bran oil, safflower oil, shea butter, soybean oil, Evening primrose oil, camellia oil, corn oil, rapeseed oil, hydrogenated rapeseed oil, palm kernel oil, hydrogenated palm kernel oil, palm oil, hydrogenated palm oil, peanut oil, hydrogenated peanut oil, castor oil, hydrogenated castor oil, sunflower oil, grapes Seed oil, jojoba oil, hardened jojoba oil, macadamia nut oil, medhome oil, vegetable oil such as cottonseed oil, hardened cottonseed oil, coconut oil, hardened coconut oil and its hardened oil, beeswax, high acid value beeswax, lanolin, reduced lanolin, liquid lanolin, Examples thereof include wax such as carnauba wax and montan wax.
【0030】シリコーン系の油相成分:ジメチルポリシ
ロキサン、メチルフェニルポリシロキサン、メチルシク
ロポリシロキサン、オクタメチルポリシロキサン、デカ
メチルポリシロキサン、ドデカメチルシクロシロキサ
ン、メチルハイドロジェンポリシロキサン、ポリエーテ
ル変性オルガノポリシロキサン、ジメチルシロキサン・
メチルセチルオキシシロキサン共重合体、ジメチルシロ
キサン・メチルステアロキシシロキサン共重合体、アル
キル変性オルガノポリシロキサン、末端変性オルガノポ
リシロキサン、ジメチコノール、シリコーンゲル、アク
リルシリコーン、トリメチルシロキシケイ酸、シリコー
ンRTVゴム等が挙げられる。Silicone-based oil phase component: dimethylpolysiloxane, methylphenylpolysiloxane, methylcyclopolysiloxane, octamethylpolysiloxane, decamethylpolysiloxane, dodecamethylcyclosiloxane, methylhydrogenpolysiloxane, polyether-modified organopoly Siloxane, dimethylsiloxane
Methylcetyloxysiloxane copolymer, dimethylsiloxane / methylstearoxysiloxane copolymer, alkyl-modified organopolysiloxane, terminal-modified organopolysiloxane, dimethiconol, silicone gel, acrylic silicone, trimethylsiloxysilicic acid, silicone RTV rubber, etc. To be
【0031】フッ素系の油相成分:パーフルオロポリエ
ーテル、フッ素変性オルガノポリシロキサン、フッ化ピ
ッチ、フルオロカーボン、フルオロアルコール、フルオ
ロアルキル・ポリオキシアルキレン共変性オルガノポリ
シロキサン等が挙げられる。Fluorine-based oil phase components: perfluoropolyether, fluorine-modified organopolysiloxane, fluorinated pitch, fluorocarbon, fluoroalcohol, fluoroalkyl / polyoxyalkylene co-modified organopolysiloxane, and the like.
【0032】(2)高級アルコールの例
ラウリルアルコール、ミリスチルアルコール、セチルア
ルコール、ステアリルアルコール、イソステアリルアル
コール、オレイルアルコール、ベヘニルアルコール、2
−エチルヘキサノール、ヘキサデシルアルコール、オク
チルドデカノール等が挙げられる。(2) Examples of higher alcohols Lauryl alcohol, myristyl alcohol, cetyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, behenyl alcohol, 2
-Ethylhexanol, hexadecyl alcohol, octyldodecanol and the like can be mentioned.
【0033】(3)脂肪酸の例
カプリル酸、カプリン酸、ウンデシレン酸、ラウリン
酸、ミリスチン酸、パルミチン酸、パルミトレイン酸、
ステアリン酸、イソステアリン酸、オレイン酸、リノー
ル酸、リノレン酸、アラキン酸、アラキドン酸、ベヘン
酸、エルカ酸、2−エチルヘキサン酸等が挙げられる。(3) Examples of fatty acids Caprylic acid, capric acid, undecylenic acid, lauric acid, myristic acid, palmitic acid, palmitoleic acid,
Examples thereof include stearic acid, isostearic acid, oleic acid, linoleic acid, linolenic acid, arachidic acid, arachidonic acid, behenic acid, erucic acid and 2-ethylhexanoic acid.
【0034】(4)紫外線吸収剤の例
パラアミノ安息香酸、パラアミノ安息香酸アミル、パラ
アミノ安息香酸エチルジヒドロキシプロピル、パラアミ
ノ安息香酸グリセリル、パラアミノ安息香酸エチル、パ
ラアミノ安息香酸オクチル、パラアミノ安息香酸オクチ
ルジメチル、サリチル酸エチレングリコール、サリチル
酸オクチル、サリチル酸トリエタノールアミン、サリチ
ル酸フェニル、サリチル酸ブチルフェニル、サリチル酸
ベンジル、パラメトキシケイ皮酸オクチル、パラメトキ
シケイ皮酸2−エチルヘキシル、(4) Examples of UV absorbers Paraaminobenzoic acid, amyl paraaminobenzoate, ethyl dihydroxypropyl paraaminobenzoate, glyceryl paraaminobenzoate, ethyl paraaminobenzoate, octyl paraaminobenzoate, octyldimethyl paraaminobenzoate, ethylene salicylate. Glycol, octyl salicylate, triethanolamine salicylate, phenyl salicylate, butylphenyl salicylate, benzyl salicylate, octyl paramethoxycinnamate, 2-ethylhexyl paramethoxycinnamate,
【0035】ジパラメトキシケイ皮酸モノ2−エチルヘ
キサン酸グリセリル、パラメトキシケイ皮酸イソプロピ
ル、パラメトキシヒドロケイ皮酸ジエタノールアミン
塩、ジイソプロピル・ジイソプロピルケイ皮酸エステル
混合物、ウロカニン酸、ウロカニン酸エチル、ヒドロキ
シメトキシベンゾフェノン、ヒドロキシメトキシベンゾ
フェノンスルホン酸及びその塩、ジヒドロキシメトキシ
ベンゾフェノン、ジヒドロキシメトキシベンゾフェノン
ジスルホン酸ナトリウム、ジヒドロキシベンゾフェノ
ン、ジヒドロキシジメトキシベンゾフェノン、ヒドロキ
シオクトキシベンゾフェノン、テトラヒドロキシベンゾ
フェノン、ブチルメトキシジベンゾイルメタン、2,
4,6−トリアニリノ−p−(カルボ−2−エチルヘキ
シル−1−オキシ)−1,3,5−トリアジン、2−
(2−ヒドロキシ−5−メチルフェニル)ベンゾトリア
ゾール、メチル−O−アミノベンゾエート、2−エチル
ヘキシル−2−シアノ−3,3−ジフェニルアクリレー
ト、フェニルベンゾイミダゾール硫酸、3−(4−メチ
ルベンジリデン)カンフル、イソプロピルジベンゾイル
メタン、4−(3,4−ジメトキシフェニルメチレン)
−2,5−ジオキソ−1−イミダゾリジンプロピオン酸
2−エチルヘキシル等、及びこれらの高分子誘導体やシ
ラン誘導体等が挙げられる。Diparamethoxycinnamic acid mono-2-ethylhexanoate glyceryl, isopropyl paramethoxycinnamate, paramethoxyhydrocinnamic acid diethanolamine salt, diisopropyl / diisopropylcinnamic acid ester mixture, urocanic acid, ethyl urocanate, hydroxy Methoxybenzophenone, hydroxymethoxybenzophenone sulfonic acid and salts thereof, dihydroxymethoxybenzophenone, sodium dihydroxymethoxybenzophenone disulfonate, dihydroxybenzophenone, dihydroxydimethoxybenzophenone, hydroxyoctoxybenzophenone, tetrahydroxybenzophenone, butylmethoxydibenzoylmethane, 2,
4,6-trianilino-p- (carbo-2-ethylhexyl-1-oxy) -1,3,5-triazine, 2-
(2-hydroxy-5-methylphenyl) benzotriazole, methyl-O-aminobenzoate, 2-ethylhexyl-2-cyano-3,3-diphenylacrylate, phenylbenzimidazole sulfate, 3- (4-methylbenzylidene) camphor, Isopropyldibenzoylmethane, 4- (3,4-dimethoxyphenylmethylene)
Examples include 2-ethylhexyl-2,5-dioxo-1-imidazolidinepropionate and the like, and polymer derivatives and silane derivatives thereof.
【0036】(5)粉体・顔料の例
赤色104号、赤色201号、黄色4号、青色1号、黒
色401号等の色素、黄色4号ALレーキ、黄色203
号BAレーキ等のレーキ色素、ナイロンパウダー、シル
クパウダー、ウレタンパウダー、テフロン(登録商標)
パウダー、シリコーンパウダー、ポリメタクリル酸メチ
ルパウダー、セルロースパウダー、デンプン、シリコー
ンエラストマー球状粉体、ポリエチレン末等の高分子、
黄酸化鉄、赤色酸化鉄、黒酸化鉄、酸化クロム、カーボ
ンブラック、群青、紺青等の有色顔料、酸化亜鉛、酸化
チタン、酸化セリウム等の白色顔料、タルク、マイカ、
セリサイト、カオリン、板状硫酸バリウム等の体質顔
料、雲母チタン等のパール顔料、硫酸バリウム、炭酸カ
ルシウム、炭酸マグネシウム、珪酸アルミニウム、珪酸
マグネシウム等の金属塩、シリカ、アルミナ等の無機粉
体、ステアリン酸アルミニウム、ステアリン酸マグネシ
ウム、パルミチン酸亜鉛、ミリスチン酸亜鉛、ミリスチ
ン酸マグネシウム、ラウリン酸亜鉛、ウンデシレン酸亜
鉛等の金属セッケン、ベントナイト、スメクタイト、窒
化ホウ素等が挙げられる。これらの粉体の形状(球状、
棒状、針状、板状、不定形状、燐片状、紡錘状等)及び
粒子径に特に制限はない。(5) Examples of powder / pigment Pigments such as red No. 104, red No. 201, yellow No. 4, blue No. 1, black No. 401, yellow No. 4 AL lake, yellow 203
No. BA lake and other rake pigments, nylon powder, silk powder, urethane powder, Teflon (registered trademark)
Polymers such as powder, silicone powder, polymethylmethacrylate powder, cellulose powder, starch, silicone elastomer spherical powder, polyethylene powder,
Colored pigments such as yellow iron oxide, red iron oxide, black iron oxide, chromium oxide, carbon black, ultramarine blue and navy blue, white pigments such as zinc oxide, titanium oxide and cerium oxide, talc, mica,
Body pigments such as sericite, kaolin, and plate-shaped barium sulfate, pearl pigments such as mica titanium, metal salts such as barium sulfate, calcium carbonate, magnesium carbonate, aluminum silicate, magnesium silicate, inorganic powders such as silica and alumina, stearin Examples thereof include metal soaps such as aluminum acid salt, magnesium stearate, zinc palmitate, zinc myristate, magnesium myristate, zinc laurate, and zinc undecylenate, bentonite, smectite, and boron nitride. The shape of these powders (spherical,
There is no particular limitation on the particle size (rod shape, needle shape, plate shape, irregular shape, scale shape, spindle shape, etc.).
【0037】なおこれらの粉体は、従来公知の表面処
理、例えばフッ素化合物処理、シリコーン処理、シリコ
ーン樹脂処理、ペンダント処理、シランカップリング剤
処理、チタンカップリング剤処理、油剤処理、N−アシ
ル化リジン処理、ポリアクリル酸処理、金属セッケン処
理、アミノ酸処理、レシチン処理、無機化合物処理、プ
ラズマ処理、メカノケミカル処理等によって事前に表面
処理されていてもいなくても構わない。These powders are conventionally known surface treatments such as fluorine compound treatment, silicone treatment, silicone resin treatment, pendant treatment, silane coupling agent treatment, titanium coupling agent treatment, oil agent treatment, N-acylation. It may or may not be surface-treated in advance by lysine treatment, polyacrylic acid treatment, metal soap treatment, amino acid treatment, lecithin treatment, inorganic compound treatment, plasma treatment, mechanochemical treatment and the like.
【0038】(6)界面活性剤の例
アニオン性界面活性剤:脂肪酸セッケン、α−アシルス
ルホン酸塩、アルキルスルホン酸塩、アルキルアリルス
ルホン酸塩、アルキルナフタレンスルホン酸塩、アルキ
ル硫酸塩、POEアルキルエーテル硫酸塩、アルキルア
ミド硫酸塩、アルキルリン酸塩、POEアルキルリン酸
塩、アルキルアミドリン酸塩、アルキロイルアルキルタ
ウリン塩、N−アシルアミノ酸塩、POEアルキルエー
テルカルボン酸塩、アルキルスルホコハク酸塩、アルキ
ルスルホ酢酸ナトリウム、アシル化加水分解コラーゲン
ペプチド塩、パーフルオロアルキルリン酸エステル等が
挙げられる。(6) Examples of surfactants Anionic surfactants: fatty acid soap, α-acyl sulfonate, alkyl sulfonate, alkylallyl sulfonate, alkyl naphthalene sulfonate, alkyl sulfate, POE alkyl. Ether sulfate, alkyl amide sulfate, alkyl phosphate, POE alkyl phosphate, alkyl amide phosphate, alkyloyl alkyl taurine salt, N-acyl amino acid salt, POE alkyl ether carboxylate, alkyl sulfosuccinate, Examples thereof include sodium alkylsulfoacetate, acylated hydrolyzed collagen peptide salt, perfluoroalkyl phosphate ester and the like.
【0039】カチオン性界面活性剤:塩化アルキルトリ
メチルアンモニウム、塩化ステアリルトリメチルアンモ
ニウム、臭化ステアリルトリメチルアンモニウム、塩化
セトステアリルトリメチルアンモニウム、塩化ジステア
リルジメチルアンモニウム、塩化ステアリルジメチルベ
ンジルアンモニウム、臭化ベヘニルトリメチルアンモニ
ウム、塩化ベンザルコニウム、塩化ベヘニン酸アミドプ
ロピルジメチルヒドロキシプロピルアンモニウム、ステ
アリン酸ジエチルアミノエチルアミド、ステアリン酸ジ
メチルアミノエチルアミド、ステアリン酸ジメチルアミ
ノプロピルアミド、ラノリン誘導体第4級アンモニウム
塩等が挙げられる。Cationic surfactants: alkyl trimethyl ammonium chloride, stearyl trimethyl ammonium chloride, stearyl trimethyl ammonium bromide, cetostearyl trimethyl ammonium chloride, distearyl dimethyl ammonium chloride, stearyl dimethyl benzyl ammonium chloride, behenyl trimethyl ammonium bromide, chloride Examples thereof include benzalkonium, amidopropyldimethylhydroxypropylammonium behenate chloride, diethylaminoethylamide stearate, dimethylaminoethylamide stearate, dimethylaminopropylamide stearate, and lanolin derivative quaternary ammonium salt.
【0040】両性界面活性剤:カルボキシベタイン型、
アミドベタイン型、スルホベタイン型、ヒドロキシスル
ホベタイン型、アミドスルホベタイン型、ホスホベタイ
ン型、アミノカルボン酸塩型、イミダゾリン誘導体型、
アミドアミン型等が挙げられる。Amphoteric surfactant: carboxybetaine type,
Amidobetaine type, sulfobetaine type, hydroxysulfobetaine type, amidosulfobetaine type, phosphobetaine type, aminocarboxylic acid salt type, imidazoline derivative type,
Examples thereof include amidoamine type.
【0041】ノニオン性界面活性剤:プロピレングリコ
ール脂肪酸エステル、グリセリン脂肪酸エステル、ポリ
グリセリン脂肪酸エステル、ソルビタン脂肪酸エステ
ル、POEソルビタン脂肪酸エステル、POEソルビッ
ト脂肪酸エステル、POEグリセリン脂肪酸エステル、
POEアルキルエーテル、POE脂肪酸エステル、PO
E硬化ヒマシ油、POEヒマシ油、POE・POP共重
合体、POE・POPアルキルエーテル、ポリエーテル
変性シリコーンラウリン酸アルカノールアミド、アルキ
ルアミンオキシド、水素添加大豆リン脂質等が挙げられ
る。天然系界面活性剤:レシチン、サポニン、糖系界面
活性剤等が挙げられる。Nonionic surfactant: propylene glycol fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, sorbitan fatty acid ester, POE sorbitan fatty acid ester, POE sorbit fatty acid ester, POE glycerin fatty acid ester,
POE alkyl ether, POE fatty acid ester, PO
E hydrogenated castor oil, POE castor oil, POE / POP copolymer, POE / POP alkyl ether, polyether modified silicone lauric acid alkanolamide, alkylamine oxide, hydrogenated soybean phospholipid and the like can be mentioned. Natural surfactants: lecithin, saponin, sugar-based surfactants and the like.
【0042】(7)多価アルコール、糖の例
エチレングリコール、ジエチレングリコール、ポリエチ
レングリコール、プロピレングリコール、ジプロピレン
グリコール、ポリプロピレングリコール、グリセリン、
ジグリセリン、ポリグリセリン、3−メチル−1,3−
ブタンジオール、1,3−ブチレングリコール、ソルビ
トール、マンニトール、ラフィノース、エリスリトー
ル、グルコース、ショ糖、果糖、キシリトール、ラクト
ース、マルトース、マルチトール、トレハロース、アル
キル化トレハロース、混合異性化糖、硫酸化トレハロー
ス、プルラン等が挙げられる。またこれらの化学修飾体
等も使用可能である。(7) Examples of polyhydric alcohol and sugar Ethylene glycol, diethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, polypropylene glycol, glycerin,
Diglycerin, polyglycerin, 3-methyl-1,3-
Butanediol, 1,3-butylene glycol, sorbitol, mannitol, raffinose, erythritol, glucose, sucrose, fructose, xylitol, lactose, maltose, maltitol, trehalose, alkylated trehalose, mixed isomerized sugar, sulfated trehalose, pullulan. Etc. Further, these chemically modified products and the like can also be used.
【0043】(8)高分子化合物の例
アクリル酸エステル/メタクリル酸エステル共重合体
(プラスサイズ、互応化学社製)、酢酸ビニル/クロト
ン酸共重合体(レジン28-1310、NSC社製)、酢酸ビ
ニル/クロトン酸/ビニルネオデカネート共重合体(28
-2930、NSC社製)、メチルビニルエーテルマレイン
酸ハーフエステル(ガントレッツES、ISP社製)、
T−ブチルアクリレート/アクリル酸エチル/メタクリ
ル酸共重合体(ルビマー、BASF社製)、ビニルピロ
リドン/ビニルアセテート/ビニルプロピオネート共重
合体(ルビスコールVAP、BASF社製)、ビニルア
セテート/クロトン酸共重合体(ルビセットCA,BA
SF社製)、ビニルアセテート/クロトン酸/ビニルピ
ロリドン共重合体(ルビセットCAP,BASF社
製)、ビニルピロリドン/アクリレート共重合体(ルビ
フレックス、BASF社製)、アクリレート/アクリル
アミド共重合体(ウルトラホールド、BASF社製)、
ビニルアセテート/ブチルマレエート・イソボニルアク
リラート共重合体(アドバンテージ、ISP社製)、カ
ルボキシビニルポリマー(カーボポール、BFgoodrich社
製)、アクリル酸・メタクリル酸アルキル共重合体(パ
ミュレン、BFgoodrich社製)等のアニオン性高分子化合
物や、ジアルキルアミノエチルメタクリレート重合体の
酢酸両性化物(ユカフォーマー、三菱化学社製)、アク
リル酸オクチルアクリルアミド/アクリル酸ヒドロキシ
プロピル/メタクリル酸ブチルアミノエチル共重合体
(AMPHOMER、NSC社製)等の両性高分子化合物、ビニ
ルピロリドン/ジメチルアミノエチルメタクリレートの
4級化物(GAFQUAT、ISP社製)、メチルビニルイミ
ダゾリウムクロリド/ビニルピロリドン共重合体(ルビ
コート、BASF社製)等のカチオン性高分子化合物、
ポリビニルピロリドン/酢酸ビニル共重合体(ルビスコ
ールVA、BASF社製)、ビニルピロリドン/ジメチ
ルアミノエチルメタクリレート共重合体(コポリマーV
C713、ISP社製)等のノニオン性高分子化合物等
がある。また、セルロース又はその誘導体、アルギン酸
カルシウム、プルラン、寒天、ゼラチン、タマリンド種
子多糖類、キサンタンガム、カラギーナン、ハイメトキ
シルペクチン、ローメトキシルペクチン、グアーガム、
アラビアゴム、結晶セルロース、アラビノガラクタン、
カラヤガム、トラガカントガム、アルギン酸、アルブミ
ン、カゼイン、カードラン、ジェランガム、デキストラ
ン等の天然由来高分子化合物も好適に用いることができ
る。(8) Examples of polymer compounds Acrylic acid ester / methacrylic acid ester copolymer (plus size, manufactured by Kyo Kagaku Co.), vinyl acetate / crotonic acid copolymer (resin 28-1310, manufactured by NSC), Vinyl acetate / crotonic acid / vinyl neodecanoate copolymer (28
-2930, manufactured by NSC), methyl vinyl ether maleic acid half ester (Gantrez ES, manufactured by ISP),
T-butyl acrylate / ethyl acrylate / methacrylic acid copolymer (Rubimer, manufactured by BASF), vinylpyrrolidone / vinyl acetate / vinyl propionate copolymer (Rubiscol VAP, manufactured by BASF), vinyl acetate / crotonic acid Copolymer (Rubiset CA, BA
SF company), vinyl acetate / crotonic acid / vinyl pyrrolidone copolymer (Rubiset CAP, BASF company), vinyl pyrrolidone / acrylate copolymer (Rubiflex, BASF company), acrylate / acrylamide copolymer (Ultrahold) Manufactured by BASF),
Vinyl acetate / butyl maleate / isobonyl acrylate copolymer (Advantage, ISP), carboxyvinyl polymer (Carbopol, BFgoodrich), acrylic acid / alkyl methacrylate copolymer (Pamullen, BFgoodrich) Anionic polymer compounds such as acetic acid amphoteric compound of dialkylaminoethyl methacrylate polymer (Yukaformer, manufactured by Mitsubishi Chemical Corporation), octyl acrylamide acrylate / hydroxypropyl acrylate / butylaminoethyl methacrylate copolymer (AMPHOMER, NSC) Polymer), vinylpyrrolidone / dimethylaminoethylmethacrylate quaternary compound (GAFQUAT, ISP), methylvinylimidazolium chloride / vinylpyrrolidone copolymer (Rubicoat, BASF) Down polymer compound,
Polyvinylpyrrolidone / vinyl acetate copolymer (Rubiscor VA, manufactured by BASF), vinylpyrrolidone / dimethylaminoethyl methacrylate copolymer (Copolymer V
C713, manufactured by ISP) and the like. Further, cellulose or a derivative thereof, calcium alginate, pullulan, agar, gelatin, tamarind seed polysaccharide, xanthan gum, carrageenan, high methoxyl pectin, low methoxyl pectin, guar gum,
Gum arabic, crystalline cellulose, arabinogalactan,
Naturally-derived polymer compounds such as karaya gum, tragacanth gum, alginic acid, albumin, casein, curdlan, gellan gum and dextran can also be preferably used.
【0044】(9)生理活性成分の例
生理活性成分としては、皮膚に塗布した場合に皮膚に何
らかの生理活性を与える物質が挙げられる。例えば、美
白成分、抗炎症剤、老化防止剤、紫外線防御剤、スリミ
ング剤、ひきしめ剤、抗酸化剤、発毛剤、育毛剤、保湿
剤、血行促進剤、抗菌剤、殺菌剤、乾燥剤、冷感剤、温
感剤、ビタミン剤、アミノ酸、創傷治癒促進剤、刺激緩
和剤、鎮痛剤、細胞賦活剤、酵素成分等が挙げられる。(9) Examples of physiologically active ingredients Examples of the physiologically active ingredients include substances that give some kind of physiological activity to the skin when applied to the skin. For example, whitening ingredients, anti-inflammatory agents, anti-aging agents, UV protection agents, slimming agents, tightening agents, antioxidants, hair growth agents, hair growth agents, moisturizers, blood circulation promoters, antibacterial agents, bactericides, drying agents, Cooling agents, warming agents, vitamins, amino acids, wound healing promoters, stimulants, pain relievers, cell activating agents, enzyme components and the like can be mentioned.
【0045】これらの好適な配合成分の例としては、例
えばアシタバエキス、アボカドエキス、アマチャエキ
ス、アルテアエキス、アルニカエキス、アロエエキス、
アンズエキス、アンズ核エキス、イチョウエキス、ウイ
キョウエキス、ウコンエキス、ウーロン茶エキス、エイ
ジツエキス、エチナシ葉エキス、オウゴンエキス、オウ
バクエキス、オウレンエキス、オオムギエキス、オトギ
リソウエキス、オドリコソウエキス、オランダカラシエ
キス、オレンジエキス、海水乾燥物、海藻エキス、加水
分解エラスチン、加水分解コムギ末、加水分解シルク、
カモミラエキス、Examples of these suitable compounding ingredients include, for example, ashitaba extract, avocado extract, armature extract, altea extract, arnica extract, aloe extract,
Apricot extract, apricot kernel extract, ginkgo biloba extract, fennel extract, turmeric extract, oolong tea extract, ages extract, gardenia leaf extract, sardine extract, psyllium extract, laurel extract, barley extract, St. John's wort extract, scabbard extract, Dutch mustard extract, orange extract. , Dried seawater, seaweed extract, hydrolyzed elastin, hydrolyzed wheat powder, hydrolyzed silk,
Chamomile extract,
【0046】カロットエキス、カワラヨモギエキス、甘
草エキス、カルカデエキス、カキョクエキス、キウイエ
キス、キナエキス、キューカンバーエキス、グアノシ
ン、クチナシエキス、クマザサエキス、クララエキス、
クルミエキス、グレープフルーツエキス、クレマティス
エキス、クロレラエキス、クワエキス、ゲンチアナエキ
ス、紅茶エキス、酵母エキス、ゴボウエキス、コメヌカ
発酵エキス、コメ胚芽油、Carrot extract, sagebrush extract, licorice extract, karkade extract, oyster extract, kiwi extract, kina extract, cucumber extract, guanosine, gardenia extract, kumazasa extract, clara extract,
Walnut extract, grapefruit extract, clematis extract, chlorella extract, mulberry extract, gentian extract, black tea extract, yeast extract, burdock extract, rice bran extract, rice germ oil,
【0047】コンフリーエキス、コラーゲン、コケモモ
エキス、サイシンエキス、サイコエキス、サイタイ抽出
液、サルビアエキス、サボンソウエキス、ササエキス、
サンザシエキス、サンショウエキス、シイタケエキス、
ジオウエキス、シコンエキス、シソエキス、シナノキエ
キス、シモツケソウエキス、シャクヤクエキス、ショウ
ブ根エキス、シラカバエキス、スギナエキス、セイヨウ
キズタエキス、セイヨウサンザシエキス、セイヨウニワ
トコエキス、セイヨウノコギリソウエキス、セイヨウハ
ッカエキス、セージエキス、ゼニアオイエキス、センキ
ュウエキス、センブリエキス、ダイズエキス、タイソウ
エキス、タイムエキス、茶エキス、チョウジエキス、チ
ガヤエキス、チンピエキス、トウキエキス、トウキンセ
ンキカエキス、トウニンエキス、トウヒエキス、ドクダ
ミエキス、トマトエキス、納豆エキス、ニンジンエキ
ス、ニンニクエキス、ノバラエキス、ハイビスカスエキ
ス、バクモンドウエキス、パセリエキス、蜂蜜、ハマメ
リスエキス、パリエタリアエキス、ヒキオコシエキス、
ビサボロール、ビワエキス、フキタンポポエキス、フキ
ノトウエキス、ブクリョウエキス、ブッチャーブルーム
エキス、ブドウエキス、Comfrey Extract, Collagen, Cowberry Extract, Saishin Extract, Psychoextract, Saitai Extract, Salvia Extract, Soapless Extract, Sasa Extract,
Hawthorn extract, hawthorn extract, shiitake extract,
Geombu extract, shikon extract, perilla extract, linden extract, spirea extract, peony extract, ginger root extract, birch extract, horse mackerel extract, honeysuckle extract, hawthorn extract, horse mackerel extract, millet extract, mint extract, sage extract, mallow extract. , Senkyu extract, senburi extract, soybean extract, tern extract, thyme extract, tea extract, clove extract, chigaya extract, chimpi extract, touki extract, daffodil extract, tonin extract, spruce extract, dokudami extract, tomato extract, natto extract, carrot extract, Garlic extract, Novara extract, Hibiscus extract, Bakmondou extract, Parsley extract, Honey, Hamamelis extract, Parier Riaekisu, cause extract,
Bisabolol, loquat extract, coltsfoot extract, butterbur extract, butterbur extract, butcher bloom extract, grape extract,
【0048】プロポリス、ヘチマエキス、ベニバナエキ
ス、ペパーミントエキス、ボダイジュエキス、ボタンエ
キス、ホップエキス、マツエキス、マロニエエキス、ミ
ズバショウエキス、ムクロジエキス、メリッサエキス、
モモエキス、ヤグルマギクエキス、ユーカリエキス、ユ
キノシタエキス、ユズエキス、ヨクイニンエキス、ヨモ
ギエキス、ラベンダーエキス、リンゴエキス、レタスエ
キス、レモンエキス、レンゲソウエキス、ローズエキ
ス、ローズマリーエキス、ローマカミツレエキス、ロー
ヤルゼリーエキス等を挙げることができる。[0048] Propolis, loofah extract, safflower extract, peppermint extract, bodige extract, button extract, hop extract, pine extract, horse chestnut extract, sphagnum extract, sucrose extract, melissa extract,
Peach extract, cornflower extract, eucalyptus extract, Yukinoshita extract, Yuzu extract, Yukuinin extract, Artemisia extract, Lavender extract, Apple extract, Lettuce extract, Lemon extract, Astragalus extract, Rose extract, Rosemary extract, Roman chamomile extract, Royal jelly extract, etc. be able to.
【0049】また、デオキシリボ核酸、ムコ多糖類、ヒ
アルロン酸ナトリウム、コンドロイチン硫酸ナトリウ
ム、コラーゲン、エラスチン、キチン、キトサン、加水
分解卵殻膜などの生体高分子、アミノ酸、加水分解ペプ
チド、乳酸ナトリウム、尿素、ピロリドンカルボン酸ナ
トリウム、ベタイン、ホエイ、トリメチルグリシンなど
の保湿成分、スフィンゴ脂質、セラミド、フィトスフィ
ンゴシン、コレステロール、コレステロール誘導体、リ
ン脂質などの油性成分、ε−アミノカプロン酸、グリチ
ルリチン酸、β−グリチルレチン酸、塩化リゾチーム、
グアイアズレン、Deoxyribonucleic acid, mucopolysaccharide, sodium hyaluronate, sodium chondroitin sulfate, collagen, elastin, chitin, chitosan, biopolymer such as hydrolyzed eggshell membrane, amino acid, hydrolyzed peptide, sodium lactate, urea, pyrrolidone Moisturizing ingredients such as sodium carboxylate, betaine, whey, trimethylglycine, sphingolipids, ceramides, phytosphingosine, cholesterol, cholesterol derivatives, oily ingredients such as phospholipids, ε-aminocaproic acid, glycyrrhizic acid, β-glycyrrhetinic acid, lysozyme chloride ,
Guay Azulene,
【0050】ヒドロコールチゾン等の抗炎症剤、ビタミ
ンA、ビタミンB2、ビタミンB6、ビタミンC、ビタミ
ンD、ビタミンE、パントテン酸カルシウム、ビオチ
ン、ニコチン酸アミド、ビタミンCエステル等のビタミ
ン類、アラントイン、ジイソプロピルアミンジクロロア
セテート、4−アミノメチルシクロヘキサンカルボン酸
等の活性成分、トコフェロール、カロチノイド、フラボ
ノイド、タンニン、リグナン、サポニン等の抗酸化剤、
α−ヒドロキシ酸、β−ヒドロキシ酸などの細胞賦活
剤、γ−オリザノール、ビタミンE誘導体などの血行促
進剤、レチノール、レチノール誘導体等の創傷治癒剤、
アルブチン、コウジ酸、プラセンタエキス、イオウ、エ
ラグ酸、リノール酸、トラネキサム酸、グルタチオン等
の美白剤、セファランチン、カンゾウ抽出物、トウガラ
シチンキ、ヒノキチオール、ヨウ化ニンニクエキス、塩
酸ピリドキシン、DL−α−トコフェロール、酢酸DL
−α−トコフェロール、ニコチン酸、ニコチン酸誘導
体、パントテン酸カルシウム、D−パントテニルアルコ
ール、アセチルパントテニルエチルエーテル、ビオチ
ン、アラントイン、イソプロピルメチルフェノール、エ
ストラジオール、エチニルエストラジオール、塩化カプ
ロニウム、塩化ベンザルコニウム、塩酸ジフェンヒドラ
ミン、タカナール、カンフル、サリチル酸、ノニル酸バ
ニリルアミド、ノナン酸バニリルアミド、ピロクトンオ
ラミン、ペンタデカン酸グリセリル、L−メントール、
モノニトログアヤコール、レゾルシン、γ−アミノ酪
酸、塩化ベンゼトニウム、塩酸メキシレチン、オーキシ
ン、女性ホルモン、カンタリスチンキ、シクロスポリ
ン、ジンクピリチオン、ヒドロコールチゾン、ミノキシ
ジル、モノステアリン酸ポリオキシエチレンソルビタ
ン、ハッカ油、サダニシキエキス等の育毛剤などが挙げ
られる。Anti-inflammatory agents such as hydrocortisone, vitamins A such as vitamin A, vitamin B 2 , vitamin B 6 , vitamin C, vitamin D, vitamin E, calcium pantothenate, biotin, nicotinic acid amide and vitamin C ester, Allantoin, diisopropylamine dichloroacetate, active ingredients such as 4-aminomethylcyclohexanecarboxylic acid, antioxidants such as tocopherols, carotenoids, flavonoids, tannins, lignans and saponins,
Cell activating agents such as α-hydroxy acid and β-hydroxy acid, blood circulation promoting agents such as γ-oryzanol and vitamin E derivatives, wound healing agents such as retinol and retinol derivatives,
Whitening agents such as arbutin, kojic acid, placenta extract, sulfur, ellagic acid, linoleic acid, tranexamic acid, glutathione, cepharanthin, licorice extract, capsicum tincture, hinokitiol, garlic iodide extract, pyridoxine hydrochloride, DL-α-tocopherol, Acetic acid DL
-Α-tocopherol, nicotinic acid, nicotinic acid derivative, calcium pantothenate, D-pantothenyl alcohol, acetylpantothenyl ethyl ether, biotin, allantoin, isopropylmethylphenol, estradiol, ethinylestradiol, capronium chloride, benzalkonium chloride, hydrochloric acid Diphenhydramine, tacanal, camphor, salicylic acid, nonyl vanillyl amide, nonanoic vanillyl amide, piroctone olamine, glyceryl pentadecanoate, L-menthol,
Mononitroguaiacol, resorcin, γ-aminobutyric acid, benzethonium chloride, mexiletine hydrochloride, auxin, female hormone, cantharitin tincture, cyclosporine, zinc pyrithione, hydrocortisone, minoxidil, polyoxyethylene sorbitan monostearate, peppermint oil, Sadashiki extract And the like.
【0051】(10)酸化防止剤の例
亜硫酸水素ナトリウム、亜硫酸ナトリウム、エリソルビ
ン酸、エリソルビン酸ナトリウム、チオジプロピオン酸
ジラウリル、トコフェロール、トリルビグアナイド、ノ
ルジヒドログアヤレチン酸、パラヒドロキシアニソー
ル、ブチルヒドロキシアニソール、ジブチルヒドロキシ
トルエン、ステアリン酸アスコルビル、パルミチン酸ア
スコルビル、没食子酸オクチル、没食子酸プロピル、カ
ロチノイド、フラボノイド、タンニン、リグナン、サポ
ニン、リンゴエキスやチョウジエキスなどの酸化防止効
果の認められる植物エキス等が挙げられる。(10) Examples of antioxidants Sodium hydrogen sulfite, sodium sulfite, erythorbic acid, sodium erythorbate, dilauryl thiodipropionate, tocopherol, tolylbiguanide, nordihydroguaiaretinic acid, parahydroxyanisole, butylhydroxyanisole. , Dibutylhydroxytoluene, ascorbyl stearate, ascorbyl palmitate, octyl gallate, propyl gallate, carotenoids, flavonoids, tannins, lignans, saponins, apple extracts and plant extracts that have antioxidant effects such as clove extract. .
【0052】(11)溶媒の例
精製水、エタノール、低級アルコール、エーテル類、L
PG、フルオロカーボン、N−メチルピロリドン、フル
オロアルコール、揮発性直鎖状シリコーン、次世代フロ
ン等が挙げられる。(11) Examples of solvents Purified water, ethanol, lower alcohols, ethers, L
Examples thereof include PG, fluorocarbon, N-methylpyrrolidone, fluoroalcohol, volatile linear silicone, and next-generation CFC.
【0053】さらに本発明の化粧料組成物には、既存の
乳化剤等を一般的な濃度で添加することもできる。例え
ば、化粧品原料基準第二版注解、日本公定書教会編、1
984(薬事日報社)、化粧品原料基準外成分規格、厚
生省薬務局審査課監修、1993(薬事日報社)、化粧
品原料基準外成分規格追補、厚生省薬務局審査課監修、
1993(薬事日報社)、化粧品種別許可基準、厚生省
薬務局審査課監修、1993(薬事日報社)、および化
粧品原料辞典、平成3年(日光ケミカルズ)等、に記載
されている全ての薬剤が使用できる。Further, existing emulsifiers and the like can be added to the cosmetic composition of the present invention at a general concentration. For example, commentary on the Second Edition of Cosmetic Raw Material Standard, edited by the Japanese Official Book Church, 1
984 (Pharmaceutical Daily), non-standard ingredients for cosmetics, supervision by the Ministry of Health, Labor and Welfare Pharmaceutical Affairs Bureau examination section, 1993 (Yakuji Nippo), supplements for non-standard ingredients for cosmetics, supervision by Ministry of Health, Labor and Welfare Examination Division,
All the drugs listed in 1993 (Yakuji Nippo), permission criteria for each cosmetic type, supervision of the Ministry of Health, Labor and Welfare Pharmaceutical Affairs Bureau Examination Division, 1993 (Yakuji Nippo), and Cosmetic Raw Materials Dictionary, 1991 (Nikko Chemicals), etc. Can be used.
【0054】本発明の化粧料組成物が適用できる化粧料
としては、例えばファンデーション、白粉、アイシャド
ウ、アイライナー、アイブロー、チーク、口紅、ネイル
カラー等のメイクアップ化粧料;乳液、クリーム、ロー
ション、カラミンローション、サンスクリーン剤、サン
タン剤、アフターシェーブローション、プレシェーブロ
ーション、パック料、アクネ対策化粧料、エッセンス等
の基礎化粧料;シャンプー、リンス、コンディショナ
ー、ヘアカラー、ヘアトニック、セット剤、養毛料、パ
ーマネント剤等の頭髪化粧料;ボディパウダー、デオド
ラント、脱毛剤、セッケン、ボディシャンプー、入浴
剤、ハンドソープ、香水等が挙げられる。As the cosmetics to which the cosmetic composition of the present invention can be applied, for example, makeup cosmetics such as foundation, white powder, eye shadow, eyeliner, eyebrow, cheek, lipstick, nail color; milky lotion, cream, lotion, Basic cosmetics such as calamine lotion, sunscreen, suntan, aftershave lotion, preshave lotion, pack, acne-preventing cosmetic, essence, etc .; shampoo, conditioner, conditioner, hair color, hair tonic, setting agent, hair restorer, permanent Hair cosmetics such as agents; body powder, deodorant, depilatory, soap, body shampoo, bath salt, hand soap, perfume and the like.
【0055】本発明の化粧料の剤型としては、特に限定
はなく、二層状、油中水型エマルジョン、水中油型エマ
ルジョン、ジェル状、スプレー、ムース状、油性、固形
状、シート状、パウダー状など従来公知の剤型を使用す
ることができる。The dosage form of the cosmetic composition of the present invention is not particularly limited, and it may be in the form of two layers, water-in-oil emulsion, oil-in-water emulsion, gel, spray, mousse, oil, solid, sheet or powder. A conventionally known dosage form such as a shape can be used.
【0056】本発明は、環境調和型で安全性の高い殺菌
成分であるアイチュリン系ペプチドを化粧品等に配合し
て、その保存安定性を著しく高めることを目指したもの
である。The present invention aims to remarkably enhance the storage stability of an iturin-based peptide, which is an environmentally friendly and highly safe bactericidal component, by incorporating it into cosmetics and the like.
【0057】これらは機能性化粧品に含まれる、例え
ば、抗酸化作用を高めるために配合されるビタミンCの
誘導体、ビタミンEなどの脂溶性成分とも会合できるた
め、それらの物理化学的安定性を高めることができると
ともに、それらの細胞膜透過を助けることができる。Since these can associate with fat-soluble components contained in functional cosmetics, for example, vitamin C derivatives and vitamin E, which are added to enhance antioxidant activity, their physicochemical stability is enhanced. In addition to being able to do so, they can help their cell membrane permeation.
【0058】本発明において、皮膚用剤とは、例えばス
キンミルク、スキンクリーム、ファンデーションクリー
ム、マッサージクリーム、クレンジングクリーム、シェ
ービングクリーム、クレンジングフォーム、化粧水、ロ
ーション、パック、シャンプー、リンス、育毛剤、養毛
剤、染毛剤、整髪料、歯磨、うがい剤、パーマネントウ
ェーブ剤、軟膏、入浴剤、ボディーソープ等の化粧料
に、さらに医薬部外品及び医薬品としての効果効能を有
する成分が添加されているものをいう。使用時に皮膚に
接触させるものならば種類を問わない。また使用者の性
別、老若を問わない。In the present invention, the dermatological agents include, for example, skin milk, skin cream, foundation cream, massage cream, cleansing cream, shaving cream, cleansing foam, lotion, lotion, pack, shampoo, conditioner, hair restorer and hair nourishing agent. , Hair dyes, hair dressings, toothpastes, mouthwashes, permanent wave agents, ointments, bath salts, body soaps, and other cosmetics, to which ingredients effective as quasi-drugs and pharmaceuticals have been added Say. Any type may be used as long as it makes contact with the skin during use. Also, it does not matter the sex or age of the user.
【0059】たとえば、本発明の皮膚用剤には、消炎剤
サリチル酸誘導体型消炎剤、アニリン誘導体型消炎剤、
鎮けい剤、ピラゾロン誘導体型消炎剤、インドメタシン
系消炎剤、メフェナム酸系消炎剤、抗ヒスタミン剤、抗
アレルギー剤、抗炎酵素剤、ステロイド剤、グリチルリ
チン、アズレン、アラントイン等を配合することができ
る。これらの消炎剤を併用すると創傷に対する消炎効果
が促進される。その使用量は一般的には0.001〜1
0mol/L(皮膚用剤)程度でよい。For example, the dermatological agents of the present invention include anti-inflammatory agents salicylic acid derivative type anti-inflammatory agents, aniline derivative type anti-inflammatory agents,
An antispasmodic, a pyrazolone derivative-type anti-inflammatory agent, an indomethacin-based anti-inflammatory agent, a mefenamic acid-based anti-inflammatory agent, an antihistamine, an antiallergic agent, an anti-inflammatory enzyme agent, a steroid agent, glycyrrhizin, azulene, allantoin and the like can be blended. The combined use of these anti-inflammatory agents promotes the anti-inflammatory effect on wounds. The amount used is generally 0.001-1
It may be about 0 mol / L (skin preparation).
【0060】さらに、下記の(1)〜(6)の原料集に記載さ
れた成分を含有することもできる。
(1)医療薬日本医薬品集第21版1997(薬事日報社、1〜210
0項)、(2)一般薬日本医薬品集1998-99(薬事日報社、平
成9年11月10日発行、1〜1100項)、(3)第13改正日本薬局
方第一追補(薬業時報社、平成10年1月31日発行、58〜19
0 項)、(4)一般薬日本医薬品集1998-99(薬事日報社、平
成9年11月10日発行、1〜1100項)、(5)食品衛生法改正に
伴う既存添加物名簿関連法令通知集(厚生省生活衛生局
食品化学課編、1996年7月10日発行、社会保険出版社、5
〜221項)、(6)飼料添加物の成分規格等収載書第8版(日
本化学飼料協会、平成8年11月18日 発行、7〜827項)。Further, the components described in the following raw materials (1) to (6) may be contained. (1) Medical drug Japan Pharmaceutical Collection 21st Edition 1997 (Yakuji Nipposha, 1-210
(0), (2) General Medicines Japan Pharmaceutical Collection 1998-99 (Yakuji Nipposha, issued November 10, 1997, paragraphs 1 to 1100), (3) 13th Amendment Japanese Pharmacopoeia First Supplement (Pharmaceutical Industry) Jikhosha, issued January 31, 1998, 58-19
(0), (4) OTC Japanese Pharmaceuticals Collection 1998-99 (Yakuji Nipposha, issued November 10, 1997, paragraphs 1 to 1100), (5) Laws related to existing additive list due to revision of Food Sanitation Law Notifications (Ministry of Health, Health and Welfare Bureau, Food Chemistry Section, published July 10, 1996, Social Insurance Publisher, 5
-221), (6) List of constituents of feed additives, etc., 8th edition (Japan Chemical Feed Association, published November 18, 1996, paragraphs 7-827).
【0061】本発明において皮膚用剤は、アクネ、アト
ピー性皮膚炎等の皮膚疾患の予防や治療に効果的に使用
することができるものである。本発明の皮膚用剤は、剤
中に他の有効成分として、抗二キビ剤、抗男性ホルモン
剤、抗菌剤、抗炎症剤、抗酸化剤、ラジカルスカベンジ
剤、美白剤等の有効成分として一般に用いられるものを
任意に添加し併用することができる。併用される抗男性
ホルモン剤有効成分としては、シプロテロンアセテー
ト、スピロノラクトン、エストロゲン、グルココルチコ
イド等、併用される抗菌剤有効成分としては、エリスロ
マイシン、クリンダマイシン、ゲンタマイシン、ペニシ
リン、クロラムフェニコール、テトラサイクリン等の抗
生物質、ベンゾイルパーオキサイド、ナジフロキサシ
ン、エタノール、塩化ベンザルコニウム、イオウ、パラ
ヒドロキシベンゾエートエステル類、サリチル酸、ヒノ
キチオール、トリクロサン、ホモスルファミン等の抗菌
成分等、併用される抗炎症剤有効成分としてはイブプロ
フェンピコノール、グリチルリチン、カンフアー、イン
ドメタシン等があげられる。In the present invention, the dermatological agent can be effectively used for the prevention and treatment of skin diseases such as acne and atopic dermatitis. The dermatological agent of the present invention is generally used as another active ingredient in the agent, such as an anti-acne agent, an anti-androgen, an antibacterial agent, an anti-inflammatory agent, an antioxidant, a radical scavenging agent, and a whitening agent. What is used can be added arbitrarily and can be used together. Anti-androgen active ingredients used in combination are cyproterone acetate, spironolactone, estrogen, glucocorticoid, etc.Antibacterial active ingredients used in combination are erythromycin, clindamycin, gentamicin, penicillin, chloramphenicol, tetracycline. Antibiotics such as benzoyl peroxide, nadifloxacin, ethanol, benzalkonium chloride, sulfur, parahydroxybenzoate esters, salicylic acid, hinokitiol, triclosan, homosulfamine, etc. Examples include ibuprofen piconol, glycyrrhizin, camphor, indomethacin and the like.
【0062】また併用される他の抗ニキビ剤有効成分と
しては、トレチノイン、レゾルシン、イソプロピルメチ
ルフエノール、トコフェロール、アスコルビン酸等があ
げられる。さらに併用される美白剤有効成分としてはプ
ラセンタエキス、コウジ酸、エラグ酸、アルブチン、ト
ラネキサム酸エステル等があげられる。またこの他にカ
ミツレエキス、クマザサエキス、バラエキス、メリッサ
エキス、ゲンチアナエキス、カンゾウエキス、ホホバエ
キス、ローズマリ一エキス、セージエキス、タイムエキ
ス、ラベンダーエキス、ボタンエキス、ニンジンエキ
ス、アロエエキス、ダイズエキス、シソエキス、ヨモギ
エキス、ウコンエキス、ヒバエキス、ヒノキエキス、ダ
イオウエキス、オウバクエキス、オウレンエキス、イチ
ョウエキス、クワエキス、チャエキス、グレープ皮エキ
ス、エゾウコギエキス、アマチャズルエキス及び各種の
海藻抽出物等、植物由来の抗菌、抗酸化、抗炎症成分を
併用することもできる。Other anti-acne active ingredients to be used in combination include tretinoin, resorcin, isopropylmethylphenol, tocopherol, ascorbic acid and the like. Further examples of the whitening agent active ingredient used in combination include placenta extract, kojic acid, ellagic acid, arbutin, tranexamic acid ester and the like. In addition to this, chamomile extract, kumazasa extract, rose extract, melissa extract, gentian extract, licorice extract, jojoba extract, rosemary extract, sage extract, thyme extract, lavender extract, button extract, carrot extract, aloe extract, soybean extract, perilla extract, Mugwort extract, turmeric extract, hiba extract, cypress extract, rhubarb extract, pearl oyster extract, laurel extract, ginkgo extract, mulberry extract, tea extract, grape skin extract, eleuthero extract, sea chamomile extract and various seaweed extracts, plant-derived antibacterial, Antioxidant and anti-inflammatory components can also be used in combination.
【0063】これら併用される有効成分は、その種類と
用途により異なるが、0.01%から50%の範囲で添
加される。本発明における皮膚用剤は、製剤担体と共に
公知の製剤技術によって、用途に適した任意の製剤形態
として用いることができる。これらは例えば、貼付剤、
絆創膏、油性軟膏剤、水性軟膏剤、硬膏剤、リニメント
剤、ゲル剤、クリーム、美容液、ローション、乳液、化
粧水、パック、プラスター、石鹸、洗顔剤、ボディソー
プ、ヘアトリートメント剤、リンス等である。これらの
剤を調製するために添加される成分としては、通常一般
に用いられる成分を任意に用いることができる。これら
は例えば、界面活性剤、油分、アルコール類、保湿剤、
増粘剤、防腐剤、酸化防止剤、キレート剤、pH調整
剤、香料、色素、紫外線吸収剤、紫外線散乱剤、アミノ
酸類などである。The active ingredients used in combination are added in the range of 0.01% to 50%, depending on the type and use. The dermatological agent in the present invention can be used in any formulation form suitable for the purpose by a known formulation technique together with a formulation carrier. These are, for example, patches,
For plasters, oily ointments, aqueous ointments, plasters, liniments, gels, creams, serums, lotions, emulsions, lotions, packs, plasters, soaps, facial cleansers, body soaps, hair treatments, rinses, etc. is there. As a component to be added for preparing these agents, a component generally generally used can be arbitrarily used. These include, for example, surfactants, oils, alcohols, humectants,
Examples include thickeners, preservatives, antioxidants, chelating agents, pH adjusters, fragrances, dyes, ultraviolet absorbers, ultraviolet scattering agents, amino acids and the like.
【0064】本発明の皮膚用剤の用途は、ニキビに限定
されずトレチノインの適用可能な全ての用途に有効であ
る。その用途としては、皮膚炎、発毛促進に対する効果
も含まれる。例えばミノキシジル等の発毛成分とトレチ
ノインの混合処方にも使用することができる。トレチノ
インは欧米では通常0.05〜0.1の範囲で使用され
ているが、人によってはトレチノイン0.01%でも皮
膚にかぶれ、湿疹等の刺激症状が発生する場合がある。
このような場合においてトレチノイン0.1%〜0.0
01%と本発明の皮膚用剤を0.1〜10質量%で併用
するのが効果的である。The use of the dermatological agent of the present invention is not limited to acne, but is effective for all applicable uses of tretinoin. Its uses include effects on dermatitis and promotion of hair growth. For example, it can be used in a mixed formulation of a hair growth component such as minoxidil and tretinoin. Tretinoin is usually used in the range of 0.05 to 0.1 in Europe and America, but depending on the person, even 0.01% of tretinoin may cause skin irritation and irritation such as eczema.
In such cases, tretinoin 0.1% to 0.0
It is effective to use 01% and the skin preparation of the present invention in an amount of 0.1 to 10% by mass.
【0065】本発明を構成するアイチュリンについて
は、例えば、特開平7−143897号公報に開示され
ているバチルスアミロリキファシエンス株、特開平2−
209803号公報や特開平5−51305号公報に開
示されるバチルスズブチリス株が挙げられる。このよう
にアイチュリンを産生できる微生物としては、バチルス
属株がもっともよく知られており、その中でもバチルス
アミロリキファシエンス、バチルスズブチリスが有名で
ある。同様にサーファクチンについても米国特許公報5
958728号にあるようにバチルス属株が産生するこ
とが知られているが、本発明を完成するアイチュリンに
ついては、これらバチルス属株に限定されるものでない
ことは言うまでもない。Regarding iturin which constitutes the present invention, for example, Bacillus amyloliquefaciens strain disclosed in JP-A-7-143897 and JP-A-2-
The Bacillus subtilis strains disclosed in JP-A-209803 and JP-A-5-51305 can be mentioned. Thus, as a microorganism capable of producing iturin, the Bacillus strain is the most well known, and among them, Bacillus amyloliquefaciens and Bacillus subtilis are famous. Similarly, regarding Surfactin, US Pat.
It is known that Bacillus strains are produced as described in No. 957728, but it is needless to say that iturin that completes the present invention is not limited to these Bacillus strains.
【0066】[0066]
【実施例】以下、本発明の抗菌性化粧料組成物につい
て、実施例により、さらに詳しく説明するが、本発明は
これら実施例によりなんら限定されるものではない。EXAMPLES The antibacterial cosmetic composition of the present invention will be described in more detail below with reference to examples, but the present invention is not limited to these examples.
【0067】(実施例1)アイチュリン濃度と抗菌効果
との相関
予め用意した酵母細胞(Saccharomyces cerevisiae)の
培養液に、アイチュリンを表1に示すように各々0〜8
0μMの濃度範囲で混合し、室温(25℃)で5時間イ
ンキュベートした後、培養液をメンブレンフィルター
(直径0.22μm)で濾過し、濾過液に含まれる細胞
質成分を、紫外吸収(260nm及び280nm)によ
り測定した。その結果を表1に示す。Example 1 Correlation between Iturin Concentration and Antibacterial Effect Iturin was added to the previously prepared culture medium of yeast cells (Saccharomyces cerevisiae) in an amount of 0 to 8 as shown in Table 1.
After mixing in a concentration range of 0 μM and incubating at room temperature (25 ° C.) for 5 hours, the culture solution was filtered with a membrane filter (diameter: 0.22 μm) to absorb the cytoplasmic components contained in the filtrate by ultraviolet absorption (260 nm and 280 nm). ) Was measured. The results are shown in Table 1.
【0068】本試験は、アイチュリンの作用により、酵
母細胞の細胞膜が破壊された程度を観測するものであ
り、表1の数値は酵母細胞が完全に破壊された場合の最
大値(100%)に対する比率(%)を意味している。
さらにまた、アイチュリンにビタミンE(20μM)を
添加した場合についても調べた。この結果から、アイチ
ュリン濃度に依存して、酵母細胞の破壊が進むことを示
している。またビタミンEを加えても、若干の増強効果
がみられることから、アイチュリンが細胞膜に作用する
際に、脂溶性のビタミンEもそのミセル構造形成に関与
していることが伺われる。This test is to observe the extent to which the cell membrane of yeast cells was destroyed by the action of iturin, and the numerical values in Table 1 are relative to the maximum value (100%) when the yeast cells were completely destroyed. It means the ratio (%).
Furthermore, the case of adding vitamin E (20 μM) to iturin was also examined. From this result, it is shown that the destruction of yeast cells proceeds depending on the concentration of iturin. Further, since a slight enhancing effect is observed even when vitamin E is added, it is considered that fat-soluble vitamin E is also involved in the micelle structure formation when iturin acts on the cell membrane.
【0069】[0069]
【表1】 [Table 1]
【0070】(実施例2)カビ抵抗性試験
市販のアイチュリン(Iturin A:シグマ社製)を用い、
防カビ性能(カビ抵抗性試験;JIS Z2911に基づく)に
ついて試験した。試験に用いたカビは次の通りである。
これらのカビはいずれも防腐系の評価で使用される代表
的な指標菌である。Example 2 Mold Resistance Test Using commercially available iturin (Iturin A: Sigma),
The antifungal performance (mold resistance test; based on JIS Z 2911) was tested. The molds used in the test are as follows.
All of these molds are typical indicator bacteria used in the evaluation of antiseptic systems.
【0071】・Aspergillus niger ATCC 9642 ・Penicillium luteum ATCC 9644 ・Cladosporium herbarum IAM. F517 ・Trichoderma T-1 ATCC 9645 ・Chaetomium globosum ATCC 6205Aspergillus niger ATCC 9642 ・ Penicillium luteum ATCC 9644 ・ Cladosporium herbarum IAM. F517 ・ Trichoderma T-1 ATCC 9645 ・ Chaetomium globosum ATCC 6205
【0072】飼料(アイチュリン100マイクロMを含
む懸濁駅)をNo.5ろ紙に願浸させ、乾燥させたあと直
径30mmの試験片を作成した。次にJIS Z2911に準拠
して、上記の5種の混合菌懸濁液を散布した後、28℃
の培養器中で3週間培養を行い、試験片表面のカビの発
育を調べた(図1)。A feed (suspension station containing 100 μM of iturin) was immersed in No. 5 filter paper and dried to prepare a test piece having a diameter of 30 mm. Next, according to JIS Z2911, spray the mixed bacterial suspension of the above 5 species and then
Cultivation was carried out for 3 weeks in the incubator, and the growth of mold on the surface of the test piece was examined (FIG. 1).
【0073】試験は陽性対照として、一般に化粧品に用
いられるパラオキシ安息香酸エチル(0.05%)を用
い、アイチュリン試験片と比較した。それを表2に示
す。In the test, ethyl paraoxybenzoate (0.05%), which is generally used in cosmetics, was used as a positive control and compared with iturin test pieces. It is shown in Table 2.
【0074】[0074]
【表2】 [Table 2]
【0075】1‥‥試料表面のカビの発育が1/3を超
える
2‥‥試料表面のカビの発育が1/3を超えない
3‥‥試料表面にカビの発育が認められない
( )内は、『○:阻止帯がある、×:阻止帯がない』
を示す。1 ... Mold growth on the sample surface exceeds 1/3 2 ... Mold growth on the sample surface does not exceed 1/3 3 ... Mold growth is not observed on the sample surface () "○: There is a stop band, ×: There is no stop band"
Indicates.
【0076】処理条件は以下のとおり。
未処理‥‥中性化なし+温水浸漬なし
中性化‥‥「未処理」を高湿度炭酸ガス雰囲気中で中性
化
温水浸漬‥‥「未処理」を40℃温水浸漬後、中性化
この結果から、アイチュリンは優れた抗カビ性能を有し
ていることが判明した。The processing conditions are as follows. Untreated ··· No neutralization + hot water immersion Neutralization ··· “Non-treated” is neutralized in a high-humidity carbon dioxide atmosphere Hot water immersion ··· “Untreated” is neutralized after dipping in 40 ° C hot water From this result, iturin was found to have excellent antifungal performance.
【0077】(実施例3)抗菌性試験
実施例2と同様、市販のアイチュリンを用いて、抗菌性
を評価した。抗菌活性は試験した微生物に対する最小発
育阻止濃度(MIC)で評価した。その結果を表3に示
す。試験に使用した指標菌は、化粧料の防腐系の評価で
使用される代表的な菌種をはじめ、日常生活において汚
染が懸念される代表的な菌種である。(Example 3) Antibacterial property test As in Example 2, commercially available iturin was used to evaluate the antibacterial property. Antibacterial activity was evaluated by the minimum inhibitory concentration (MIC) against the microorganisms tested. The results are shown in Table 3. The indicator bacteria used in the test are representative bacterial strains used in the evaluation of the antiseptic system of cosmetics, as well as representative bacterial strains that may cause contamination in daily life.
【0078】[0078]
【表3】 [Table 3]
【0079】この結果、アイチュリンは低濃度で広い抗
菌活性が発揮されていることが明らかとなった。As a result, it became clear that iturin exerts a broad antibacterial activity at low concentrations.
【0080】(実施例4)ビタミンの皮膚浸透性を高め
る効果
ヒト皮膚再構築モデルとして市販されているTESTS
KIN(東洋紡)を用い、L−アスコルビン酸パルミチ
ン酸エステル(AAP)を角層側から投与し、アイチュ
リン(80μM)の有無で、それが皮膚に浸透した後に
変換されるアスコルビン酸の量及び変換されずに浸透し
たL−アスコルビン酸パルミチン酸エステルを定量して
評価した。Example 4 Effect of Vitamin to Increase Skin Permeability TESTS commercially available as a model for reconstructing human skin
Using KIN (Toyobo), L-ascorbyl palmitate (AAP) was administered from the horny layer side, and in the presence or absence of iturin (80 μM), the amount and conversion of ascorbic acid converted after penetrating the skin The L-ascorbic acid palmitate permeated without the treatment was quantified and evaluated.
【0081】試験方法は、L−アスコルビン酸パルミチ
ン酸エステル(シグマ社製)100、200mM溶液を
ヒト皮膚3次モデルに載せ、37℃、5%CO2存在下
で2時間静置した後、カルシウムイオンフリーのリン酸
緩衝液(pH7.2)で洗浄し、凍結保存した。これを
0.2%のリン酸を含むアセトニトリル溶液を用いてホ
モジネートし、遠心(12,000rpm×5min)
して濾過した後、HPLCで濾液に含まれるアスコルビ
ン酸(nmol/mg protein)を定量した。その結果を表4
に示す。The test method was as follows: L-ascorbyl palmitate (manufactured by Sigma) 100 and 200 mM solutions were placed on a third model of human skin, allowed to stand at 37 ° C. in the presence of 5% CO 2 for 2 hours, and then calcium. It was washed with an ion-free phosphate buffer (pH 7.2) and stored frozen. This was homogenized with an acetonitrile solution containing 0.2% phosphoric acid and centrifuged (12,000 rpm × 5 min).
After filtration, the ascorbic acid (nmol / mg protein) contained in the filtrate was quantified by HPLC. The results are shown in Table 4.
Shown in.
【0082】[0082]
【表4】 [Table 4]
【0083】この結果、アイチュリンはL−アスコルビ
ン酸パルミチン酸エステルの皮膚浸透を助ける効果があ
ることがはじめて明らかとなった。これはアイチュリン
がつくるミセルに、L−アスコルビン酸パルミチン酸エ
ステルの脂溶性部位が相互作用して、その酸化修飾が保
護されるためだと考えられる。As a result, it became clear for the first time that iturin has an effect of assisting skin penetration of L-ascorbyl palmitate. It is considered that this is because the lipid-soluble site of L-ascorbyl palmitate ester interacts with the micelle formed by iturin to protect its oxidative modification.
【0084】(実施例5)抗菌性化粧料の調整(クリー
ム)
下記処方によりクリームを調整した。即ち、(1)〜(6)、
(10)を加熱溶解し、70℃に保つ(油相)。これに(7)
をかき混ぜながら加え溶解させる。次に(8)〜(9)を(11)
に加熱溶解したものに、かき混ぜながら油相を加える。
ホモミキサー処理した後、急冷してクリームを得た。Example 5 Preparation of Antibacterial Cosmetic (Cream) A cream was prepared according to the following formulation. That is, (1) to (6),
(10) was melted by heating and kept at 70 ° C (oil phase). To this (7)
Add while stirring to dissolve. Next, change (8) to (9) to (11)
While stirring, add the oil phase to the one that was heated and dissolved.
After treatment with a homomixer, it was rapidly cooled to obtain a cream.
【0085】以下、配合組成値は質量%を表す. (1)ワセリン 8.0 (2)ラノリン 2.0 (3)スクワラン 20.0 (4)セタノール 5.0 (5)モノステアリン酸グリセロール 2.0 (6)ポリオキシエチレンモノラウリン酸ソルビタン(20EO) 2.0 (7)アイチュリン 0.7 (8)グリセロール(86%) 5.0 (9)1,3−ブチレングリコール 5.0 (10)香料 0.1 (11)精製水 50.2Hereinafter, the compounding composition values represent% by mass. (1) Vaseline 8.0 (2) Lanolin 2.0 (3) Squalane 20.0 (4) Cetanol 5.0 (5) Glycerol monostearate 2.0 (6) Polyoxyethylene sorbitan monolaurate (20EO) 2.0 (7) Aitulin 0.7 (8) Glycerol (86%) 5.0 (9) 1,3-butylene glycol 5.0 (10) Perfume 0.1 (11) Purified water 50.2
【0086】(実施例6)抗菌性化粧料の調整(化粧
水)
下記処方により化粧水を調整した。即ち、(1)〜(6)の各
成分を順次(7)に添加し、均一に混合して調整する。Example 6 Preparation of Antibacterial Cosmetic (Lotion) Lotion was prepared according to the following formulation. That is, the components (1) to (6) are sequentially added to (7) and mixed uniformly to adjust.
【0087】 (1)エタノール 0.5 (2)1,3−ブチレングリコール 10.0 (3)グリセリン 2.0 (4)ポリオキシエチレン硬化ヒマシ油 0.6 (5)アイチュリン 1.0 (6)香料 0.06 (7)精製水 85.84[0087] (1) Ethanol 0.5 (2) 1,3-butylene glycol 10.0 (3) Glycerin 2.0 (4) Polyoxyethylene hydrogenated castor oil 0.6 (5) Iturin 1.0 (6) Fragrance 0.06 (7) Purified water 85.84
【0088】(実施例7)抗菌性化粧料の調整(乳液)
下記処方により乳液を調整した。即ち、(1)〜(6)の油相
を混合し、加熱融解して75℃に保つ。一方、(7)〜(1
0)の水相を混合し、加熱溶解して75℃とし、これに前
記油相を攪拌しながら添加して乳化する。冷却後40℃
にて(11)、(12)を添加、混合する。Example 7 Preparation of Antibacterial Cosmetic (Emulsion) An emulsion was prepared according to the following formulation. That is, the oil phases (1) to (6) are mixed, heated and melted and kept at 75 ° C. On the other hand, (7) ~ (1
The aqueous phase (0) is mixed, dissolved by heating to 75 ° C., and the above oil phase is added thereto with stirring to emulsify. 40 ℃ after cooling
At (11) and (12) are added and mixed.
【0089】 (1)スクワラン 4.0 (2)トリ−2−エチルヘキサン酸グリセリル 2.0 (3)2−エチルヘキサン酸セチル 3.0 (4)セタノール 0.6 (5)ステアリルアルコール 0.4 (6)ソルビタンモノステアリン酸エステル 1.2 (7)1,3−ブチレングリコール 6.0 (8)ジプロピレングリコール 4.0 (9)ポリオキシエチレン(20EO)ソルビタンモノステアリン酸エステル 0. 8 (10)精製水 76.4 (11)アイチュリン 1.5 (12)香料 0.1[0089] (1) Squalane 4.0 (2) Glyceryl tri-2-ethylhexanoate 2.0 (3) Cetyl 2-ethylhexanoate 3.0 (4) Cetanol 0.6 (5) Stearyl alcohol 0.4 (6) Sorbitan monostearate 1.2 (7) 1,3-butylene glycol 6.0 (8) Dipropylene glycol 4.0 (9) Polyoxyethylene (20EO) sorbitan monostearate ester 8 (10) Purified water 76.4 (11) Iturin 1.5 (12) Perfume 0.1
【0090】(実施例8)抗菌性化粧料の調整(メイク
アップベースクリーム)
下記処方によりメイクアップベースクリームを調整し
た。即ち、(10)〜(12)を(4)で混練し、これを(5)〜(7)
の水相に添加、混合し、70℃に加熱する。一方、(1)
〜(3)の油相成分を混合、加熱して70℃とし、これを
前記水相に攪拌しながら添加して乳化する。乳化後冷却
して40℃にて(8)〜(9)を添加する。Example 8 Preparation of Antibacterial Cosmetic (Makeup Base Cream) A makeup base cream was prepared according to the following formulation. That is, (10) ~ (12) is kneaded in (4), this (5) ~ (7)
Is added to the aqueous phase, mixed and heated to 70 ° C. On the other hand, (1)
The oil phase components (3) to (3) are mixed and heated to 70 ° C., and this is added to the aqueous phase with stirring to emulsify. After emulsification, the mixture is cooled and (8) to (9) are added at 40 ° C.
【0091】 (1)ステアリン酸 12.0 (2)セタノール 2.0 (3)自己乳化型グリセリルモノステアリン酸エステル 2.0 (4)プロピレングリコール 10.0 (5)グリセリン 3.0 (6)水酸化カリウム 0.3 (7)精製水 67.6 (8)アイチュリン 1.5 (9)香料 0.1 (10)二酸化チタン 1.0 (11)ベンガラ 0.1 (12)黄酸化鉄 0.4[0091] (1) Stearic acid 12.0 (2) Cetanol 2.0 (3) Self-emulsifying glyceryl monostearate 2.0 (4) Propylene glycol 10.0 (5) Glycerin 3.0 (6) Potassium hydroxide 0.3 (7) Purified water 67.6 (8) Iturin 1.5 (9) Perfume 0.1 (10) Titanium dioxide 1.0 (11) Bengala 0.1 (12) Yellow iron oxide 0.4
【0092】(実施例9)抗菌性化粧料の調整(乳液状
ファンデーション)
下記処方により乳液状ファンデーションを調整した。即
ち、(15)〜(19)の顔料を混合後、粉砕機により粉砕す
る。(12)を70℃に加熱し、(9)を加えてよく膨潤さ
せ、これにあらかじめ(8)を(10)に分散させたものを加
え、さらに(11)を添加し、溶解させる。(1)〜(7)の油相
は混合し、加熱融解して80℃とする。前記顔料を水相
に攪拌しながら加え、コロイドミルを通して75℃と
し、前記油相を攪拌しながら加えて乳化し、冷却後40
℃にて、(13)〜(14)を添加する。(Example 9) Preparation of antibacterial cosmetic (milky liquid foundation) A milky liquid foundation was prepared by the following formulation. That is, the pigments (15) to (19) are mixed and then pulverized by a pulverizer. (12) is heated to 70 ° C., (9) is added to swell well, (8) is dispersed in (10) in advance, and (11) is further added and dissolved. The oil phases (1) to (7) are mixed, heated and melted to 80 ° C. The pigment is added to the aqueous phase with stirring, and the mixture is passed through a colloid mill to 75 ° C., the oil phase is added with stirring to emulsify, and after cooling 40
(13) to (14) are added at ℃.
【0093】 (1)ステアリン酸 2.4 (2)モノステアリン酸プロピレングリコール 2.0 (3)セトステアリルアルコール 0.2 (4)液状ラノリン 2.0 (5)流動パラフィン 3.0 (6)ミリスチン酸イソプロピル 8.5 (7)グリセリルモノステアリルエーテル 3.5 (8)カルボキシメチルセルロースナトリウム 0.2 (9)ベントナイト 0.5 (10)イソプレングリコール 4.0 (11)トリエタノールアミン 1.1 (12)精製水 52.5 (13)アイチュリン 2.0 (14)香料 0.1 (15)酸化チタン 8.0 (16)タルク 4.0 (17)ベンガラ 3.0 (18)黄酸化鉄 2.5 (19)黒酸化鉄 0.5[0093] (1) Stearic acid 2.4 (2) Propylene glycol monostearate 2.0 (3) Cetostearyl alcohol 0.2 (4) Liquid lanolin 2.0 (5) Liquid paraffin 3.0 (6) Isopropyl myristate 8.5 (7) Glyceryl monostearyl ether 3.5 (8) Carboxymethyl cellulose sodium 0.2 (9) Bentonite 0.5 (10) Isoprene glycol 4.0 (11) Triethanolamine 1.1 (12) Purified water 52.5 (13) Aitulin 2.0 (14) Perfume 0.1 (15) Titanium oxide 8.0 (16) Talc 4.0 (17) Bengala 3.0 (18) Yellow iron oxide 2.5 (19) Black iron oxide 0.5
【0094】(実施例10)抗菌性化粧料の調整(クリ
ーム状ファンデーション)
下記処方によりクリーム状ファンデーションを調整し
た。即ち、(13)〜(19)の顔料を混合後、粉砕機により粉
砕する。(7)〜(10)を混合、溶解させ、加熱する。(1)〜
(6)の油相は混合し、加熱溶解して80℃とする。前記
顔料を水相に攪拌しながら加え、コロイドミルを通して
75℃とし、前記油相を攪拌しながら加えて乳化し、冷
却後40℃にて(11)〜(12)を添加する。Example 10 Preparation of Antibacterial Cosmetic (Cream Foundation) A cream foundation was prepared according to the following formulation. That is, the pigments (13) to (19) are mixed and then pulverized by a pulverizer. Mix (7) to (10), dissolve and heat. (1) ~
The oil phase of (6) is mixed, heated and dissolved to 80 ° C. The pigment is added to the aqueous phase with stirring, the temperature is raised to 75 ° C. through a colloid mill, the oil phase is added with stirring to emulsify, and after cooling, (11) to (12) are added at 40 ° C.
【0095】 (1)ステアリン酸 5.0 (2)親油型グリセリルモノステアリン酸エステル 2.5 (3)モノラウリン酸プロピレングリコール 3.0 (4)セトステアリルアルコール 1.0 (5)流動パラフィン 7.0 (6)ミリスチン酸イソプロピル 8.0 (7)ジグリセリン 3.0 (8)トリエチレングリコール 2.0 (9)トリエタノールアミン 1.2 (10)精製水 44.2 (11)アイチュリン 2.0 (12)香料 0.1 (13)酸化チタン 8.0 (14)カオリン 5.0 (15)タルク 2.0 (16)ベントナイト 1.0 (17)ベンガラ 2.6 (18)黄酸化鉄 2.1 (19)黒酸化鉄 0.3[0095] (1) Stearic acid 5.0 (2) Lipophilic glyceryl monostearate 2.5 (3) Propylene glycol monolaurate 3.0 (4) cetostearyl alcohol 1.0 (5) Liquid paraffin 7.0 (6) Isopropyl myristate 8.0 (7) Diglycerin 3.0 (8) Triethylene glycol 2.0 (9) Triethanolamine 1.2 (10) Purified water 44.2 (11) Iturin 2.0 (12) Perfume 0.1 (13) Titanium oxide 8.0 (14) Kaolin 5.0 (15) Talc 2.0 (16) Bentonite 1.0 (17) Bengalla 2.6 (18) Yellow iron oxide 2.1 (19) Black iron oxide 0.3
【0096】(実施例11)抗菌性化粧料の調整(乳液
型アイカラー)
下記処方により乳化型アイカラーを調整した。即ち、
(5)〜(8)の水相を混合、溶解して加熱し、これにあらか
じめ混合、粉砕した(12)、(13)を添加、分散し、75℃
に加熱する。これにあらかじめ混合、加熱して均一とし
た(1)〜(4)を攪拌しながら添加して乳化し、冷却後(9)
〜(11)を添加、混合する。Example 11 Preparation of Antibacterial Cosmetic (Emulsion Eye Color) An emulsion eye color was prepared according to the following formulation. That is,
The aqueous phases (5) to (8) were mixed, dissolved and heated, and (12) and (13) which had been mixed and pulverized in advance were added to and dispersed in the aqueous phase, and the temperature was 75 ° C.
Heat to. Premixed and heated to make it uniform (1) to (4) with stirring to emulsify and after cooling (9)
~ (11) are added and mixed.
【0097】 (1)ステアリン酸 8.0 (2)白色ワセリン 15.0 (3)パルミチン酸イソプロピル 5.0 (4)ラノリン 5.0 (5)1,3-ブチレングリコール 5.0 (6)ヘキシレングリコール 5.0 (7)トリエタノールアミン 2.0 (8)精製水 51.08 (9)アイチュリン 1.0 (10)ラベンダーエタノール抽出物 1.25 (11)香料 0.15 (12)赤色221号 0.02 (13)群青 1.5[0097] (1) Stearic acid 8.0 (2) White petrolatum 15.0 (3) Isopropyl palmitate 5.0 (4) Lanolin 5.0 (5) 1,3-butylene glycol 5.0 (6) Hexylene glycol 5.0 (7) Triethanolamine 2.0 (8) Purified water 51.08 (9) Iturin 1.0 (10) Lavender ethanol extract 1.25 (11) Perfume 0.15 (12) Red 221 0.02 (13) Ultramarine 1.5
【0098】(実施例12)抗菌性化粧料の調整(乳化
型チークカラー)
下記処方により乳化型チークカラーを調整した。即ち、
(11)〜(13)の水相を混合、溶解して加熱し、これにあら
かじめ混合、粉砕した(16)、(17)を添加、分散し、75
℃に加熱する。これにあらかじめ混合、加熱して均一と
した(1)〜(10)を攪拌しながら添加して乳化し、冷却後
(14)〜(15)を添加、混合する。Example 12 Preparation of Antibacterial Cosmetic (Emulsified Cheek Color) An emulsified cheek color was prepared according to the following formulation. That is,
The aqueous phases (11) to (13) are mixed, dissolved and heated, and (16) and (17) previously mixed and pulverized are added to and dispersed in the mixture.
Heat to ℃. Premixed and heated to make uniform (1) to (10) with stirring to emulsify and after cooling
(14) to (15) are added and mixed.
【0099】 (1)ミツロウ 3.0 (2)ステアリン酸 2.0 (3)セタノール 3.0 (4)ラノリン 3.0 (5)流動パラフィン 15.0 (6)ミリスチン酸イソプロピル 7.0 (7)ポリオキシエチレン(20EO)ソルビタンモノステアリン酸エステル 4.2 (8)ソルビタンモノステアリン酸エステル 1.8 (9)グリセリルモノステアリン酸エステル 2.0 (10)グリセリルモノパルミチルエーテル 2.0 (11)プロピレングリコール 5.0 (12)トリエタノールアミン 0.6 (13)精製水 46.95 (14)アイチュリン 2.0 (15)香料 0.15 (16)赤色202号 0.05 (17)黄酸化鉄 2.25[0099] (1) Beeswax 3.0 (2) Stearic acid 2.0 (3) Cetanol 3.0 (4) Lanolin 3.0 (5) Liquid paraffin 15.0 (6) Isopropyl myristate 7.0 (7) Polyoxyethylene (20EO) sorbitan monostearate 4.2 (8) Sorbitan monostearate 1.8 (9) Glyceryl monostearate 2.0 (10) Glyceryl monopalmityl ether 2.0 (11) Propylene glycol 5.0 (12) Triethanolamine 0.6 (13) Purified water 46.95 (14) Iturin 2.0 (15) Perfume 0.15 (16) Red No. 202 0.05 (17) Yellow iron oxide 2.25
【0100】(実施例13)抗菌性化粧料の調整(乳化
型アイライナー)
下記処方により乳化型アイライナーを調整した。即ち、
(1)〜(4)の油相成分を混合・加熱して溶解させる。これ
に(5)〜(8)の水相を混合、加熱し、攪拌しながら加えて
乳化する。次いで、この乳化物に(11)〜(13)を加え、コ
ロイドミルを通して分散させた後冷却し、40℃にて
(9)〜(10)を加える。(Example 13) Preparation of antibacterial cosmetics (emulsion type eyeliner) An emulsion type eyeliner was prepared by the following formulation. That is,
The oil phase components (1) to (4) are mixed and heated to dissolve them. The aqueous phases (5) to (8) are mixed with this, heated, and added with stirring to emulsify. Next, add (11) to (13) to this emulsion, disperse through a colloid mill, cool, and then at 40 ° C.
Add (9) to (10).
【0101】 (1)ステアリン酸 3.5 (2)ミツロウ 2.0 (3)カルナバロウ 0.5 (4)マイクロクリスタリンワックス 5.0 (5)1,3-ブチレングリコール 7.0 (6)エチレングリコールモノブチルエーテル 2.5 (7)トリエタノールアミン 1.5 (8)精製水 45.9 (9)アイチュリン 2.0 (10)香料 0.1 (11)3.0質量%ベントナイト抽出物 20.0 (12)酸化チタン 8.0 (13)カーボンブラック 2.0[0101] (1) Stearic acid 3.5 (2) Beeswax 2.0 (3) Carnavalou 0.5 (4) Microcrystalline wax 5.0 (5) 1,3-butylene glycol 7.0 (6) Ethylene glycol monobutyl ether 2.5 (7) Triethanolamine 1.5 (8) Purified water 45.9 (9) Iturin 2.0 (10) Perfume 0.1 (11) 3.0% by mass bentonite extract 20.0 (12) Titanium oxide 8.0 (13) Carbon black 2.0
【0102】(実施例14)抗菌性化粧料の調整(水性
懸濁型マスカラ)
下記処方により水性懸濁型マスカラを調整した。即ち、
(9)に(2)〜(6)を添加して溶解させ、次いで(7)〜(8)を
添加し、コロイドミルを通して分散させる。これに(1)
を加え、均一に分散させる。Example 14 Preparation of Antibacterial Cosmetic (Aqueous Suspension Mascara) An aqueous suspension mascara was prepared according to the following formulation. That is,
(2) to (6) are added to and dissolved in (9), and then (7) to (8) are added and dispersed through a colloid mill. To this (1)
Add and disperse evenly.
【0103】 (1)50質量%酢酸ビニルエマルジョン 37.0 (2)カルボキシメチルセルロースナトリウム 1.0 (3)1,3-ブチレングリコール 3.5 (4)エチレングリコールモノメチルエーテル 3.5 (5)アイチュリン 1.0 (6)酸化チタン 8.0 (7)カーボンブラック 1.6 (8)ベンガラ 0.4 (9)精製水 44.0[0103] (1) 50% by mass vinyl acetate emulsion 37.0 (2) Sodium carboxymethyl cellulose 1.0 (3) 1,3-butylene glycol 3.5 (4) Ethylene glycol monomethyl ether 3.5 (5) Iturin 1.0 (6) Titanium oxide 8.0 (7) Carbon black 1.6 (8) Bengala 0.4 (9) Purified water 44.0
【0104】(実施例15)抗菌性化粧料の調整(クレ
ンジングジェル)下記処方によりクレンジングジェルを
調整した。即ち、(3)、(7)を(11)に添加し均一とした
後、70℃に加熱して均一に溶解させる。次いで冷却し
て40℃にて(9)〜(10)を添加し、最後に(8)を加えて中
和する。Example 15 Preparation of Antibacterial Cosmetic (Cleansing Gel) A cleansing gel was prepared according to the following formulation. That is, after adding (3) and (7) to (11) to make them uniform, they are heated to 70 ° C. and uniformly dissolved. Then, after cooling, (9) to (10) are added at 40 ° C., and finally (8) is added to neutralize.
【0105】 (1)グリセリン 15.0 (2)1,3-ブチレングリコール 10.0 (3)無水ケイ酸 7.0 (4)ポリオキシエチレン(20EO)ラウリルエーテル 5.0 (5)ポリオキシエチレン(20EO)硬化ヒマシ油 2.5 (6)ジエチレングリコールモノエチルエーテル 5.0 (7)カルボキシビニルポリマー 0.5 (8)水酸化カリウム 0.45 (9)アイチュリン 2.0 (10)香料 0.1 (11)精製水 52.45[0105] (1) Glycerin 15.0 (2) 1,3-butylene glycol 10.0 (3) Silicic anhydride 7.0 (4) Polyoxyethylene (20EO) lauryl ether 5.0 (5) Polyoxyethylene (20EO) hydrogenated castor oil 2.5 (6) Diethylene glycol monoethyl ether 5.0 (7) Carboxyvinyl polymer 0.5 (8) Potassium hydroxide 0.45 (9) Iturin 2.0 (10) Perfume 0.1 (11) Purified water 52.45
【0106】(実施例16)抗菌性化粧料の調整(ヘア
リンス)
下記処方によりヘアリンスを調整した。即ち、(9)に
(5)、(7)を加え、70℃に加熱する。一方、(1)〜(4)を
混合、溶解し、70℃に加熱する。この油相を攪拌しな
がら、先に調製した水相に徐々に加えて予備乳化し、ホ
モミキサーを加えて均一とした後冷却し、40℃にて
(6)、(8)を添加する。(Example 16) Preparation of antibacterial cosmetics (hair rinse) Hair rinse was prepared according to the following formulation. That is, in (9)
Add (5) and (7) and heat to 70 ° C. On the other hand, (1) to (4) are mixed, dissolved and heated to 70 ° C. While stirring this oil phase, gradually add it to the previously prepared aqueous phase to pre-emulsify it, add a homomixer to homogenize it, and then cool at 40 ° C.
Add (6) and (8).
【0107】 (1)セタノール 3.0 (2)塩化ステアリルトリメチルアンモニウム 0.7 (3)シリコーン油 3.0 (4)ポリオキシエチレン(10EO)オレイルエーテル 1.0 (5)グリセリン 5.0 (6)アイチュリン 1.5 (7)緑色3号1質量%水溶液 0.2 (8)香料 0.1 (9)精製水 85.5[0107] (1) Cetanol 3.0 (2) Stearyl trimethyl ammonium chloride 0.7 (3) Silicone oil 3.0 (4) Polyoxyethylene (10EO) oleyl ether 1.0 (5) Glycerin 5.0 (6) Iturin 1.5 (7) Green No. 3 1% by mass aqueous solution 0.2 (8) Perfume 0.1 (9) Purified water 85.5
【0108】(実施例17)抗菌性化粧料の調整(ヘア
トリートメント)
下記処方によりヘアトリートメントを調整した。即ち、
(1)〜(7)の油相成分を混合、加熱して80℃とする。一
方、(8)〜(10)の水相成分を混合、加熱して85℃と
し、これに前記油相を添加して乳化し、冷却後、40℃
にて(11)〜(12)を添加する。Example 17 Preparation of Antibacterial Cosmetic (Hair Treatment) Hair treatment was prepared according to the following formulation. That is,
The oil phase components (1) to (7) are mixed and heated to 80 ° C. On the other hand, the water phase components (8) to (10) are mixed and heated to 85 ° C., the oil phase is added to this to emulsify, and after cooling, 40 ° C.
(11) to (12) are added at.
【0109】 (1)ポリオキシエチレン(30EO)ベヘニルエーテル 4.0 (2)自己乳化型グリセリルモノステアレート 6.0 (3)ミリスチン酸イソプロピル 5.0 (4)ヘキシルデカノール 5.0 (5)スクワラン 3.0 (6)精製ラノリン 3.0 (7)ステアリン酸 5.0 (8)ラウリルジメチルアミノ酢酸ベタイン 5.0 (9)グリセリン 10.0 (10)精製水 52.8 (11)香料 0.2 (12)アイチュリン 1.0[0109] (1) Polyoxyethylene (30EO) behenyl ether 4.0 (2) Self-emulsifying glyceryl monostearate 6.0 (3) Isopropyl myristate 5.0 (4) Hexyldecanol 5.0 (5) Squalane 3.0 (6) Purified lanolin 3.0 (7) Stearic acid 5.0 (8) Lauryl dimethylamino acetic acid betaine 5.0 (9) Glycerin 10.0 (10) Purified water 52.8 (11) Perfume 0.2 (12) Iturin 1.0
【0110】(実施例18)抗菌性化粧料の調整(洗顔
料)
下記処方により洗顔料を調整した。即ち、(1)〜(6)の油
相及び(7)、(8)の水相をそれぞれ65℃に混合加熱溶解
した後、油相に水相を加えて乳化する。冷却後、40℃
で(9)〜(10)を添加して混合する。(Example 18) Preparation of antibacterial cosmetic (facial cleanser) A facial cleanser was prepared according to the following formulation. That is, the oil phase of (1) to (6) and the water phase of (7) and (8) are mixed and melted at 65 ° C., respectively, and then melted, and then the water phase is added to the oil phase to emulsify. After cooling, 40 ℃
Then, (9) to (10) are added and mixed.
【0111】 (1)流動パラフィン 25.0 (2)セタノール 2.0 (3)ラノリン 2.0 (4)モノステアリン酸グリセリル 5.0 (5)ポリオキシエチレンステアリルエーテル 5.0 (6)ポリオキシエチレン(20EO)ソルビタンモノステアレート 1.0 (7)1,3-ブチレングリコール 10.0 (8)精製水 48.4 (9)香料 0.1 (10)アイチュリン 1.5[0111] (1) Liquid paraffin 25.0 (2) Cetanol 2.0 (3) Lanolin 2.0 (4) Glyceryl monostearate 5.0 (5) Polyoxyethylene stearyl ether 5.0 (6) Polyoxyethylene (20EO) sorbitan monostearate 1.0 (7) 1,3-butylene glycol 10.0 (8) Purified water 48.4 (9) Perfume 0.1 (10) Iturin 1.5
【0112】(実施例19)抗菌性化粧料の調整(ボデ
ィシャンプー)
下記処方によりボディシャンプーを調整した。即ち、
(1)〜(8)の各成分を順次(9)に添加し、均一に混合す
る。Example 19 Preparation of Antibacterial Cosmetic (Body Shampoo) A body shampoo was prepared according to the following formulation. That is,
The components (1) to (8) are sequentially added to (9) and mixed uniformly.
【0113】 (1)ラウリルエーテル硫酸ナトリウム 20.0 (2)ミリスチルエーテル硫酸ナトリウム 10.0 (3)カプリン酸ジエタノールアミド 3.0 (4)ポリオキシプロピレン(10PO)ポリオキシエチレン(20EO)セチルエーテル 3.5 (5)塩化ナトリウム 2.5 (6)グリセリン 10.0 (7)アイチュリン 0.5 (8)香料 0.3 (9)精製水 50.2[0113] (1) Sodium lauryl ether sulfate 20.0 (2) Myristyl ether sodium sulfate 10.0 (3) Capric acid diethanolamide 3.0 (4) Polyoxypropylene (10PO) Polyoxyethylene (20EO) cetyl ether 3.5 (5) Sodium chloride 2.5 (6) Glycerin 10.0 (7) Aitulin 0.5 (8) Perfume 0.3 (9) Purified water 50.2
【0114】次に、上記の実施例5〜19について、抗
菌活性、皮膚刺激性及び使用時の不快感について評価を
行った。Next, the above Examples 5 to 19 were evaluated for antibacterial activity, skin irritation and discomfort during use.
【0115】(1)抗菌活性の評価
細菌として大腸菌(Escherichia coli)、黄色ブドウ球
菌(Staphylococcus aureus)及び緑膿菌(Pseudomonas
aeruginosa)を、真菌としてカンジダ(Candida albica
ns)及び黒カビ(Asperugillus niger)を用いて、試料
1g当たり細菌は106個、真菌は105個を植菌し、3
7℃及び25℃でそれぞれ培養し、2週間後に、細菌に
ついては死滅した場合、真菌については生菌数が1/1
000以下となった場合に合格であると判断した。なお
抗菌力試験結果は、表において合格したものを「○」、
不合格のものを「×」として示した。(1) Evaluation of antibacterial activity As bacteria, Escherichia coli, Staphylococcus aureus and Pseudomonas
aeruginosa) as a fungus, Candida albica
ns) and black mold (Asperugillus niger) were used to inoculate 10 6 bacteria and 10 5 fungi per 1 g of the sample, and 3
After culturing at 7 ° C and 25 ° C respectively, two weeks later, when the bacteria were killed, the viable count was 1/1 for the fungi.
When it was 000 or less, it was judged as a pass. In addition, the antibacterial activity test results are those that passed in the table are "○",
Those that failed were indicated as “x”.
【0116】[0116]
【表5】 [Table 5]
【0117】表5において明らかなように、本発明の実
施例5〜19においては、いずれも細菌及び真菌の双方
に対して十分な抗菌活性が認められた。As is clear from Table 5, in Examples 5 to 19 of the present invention, sufficient antibacterial activity against both bacteria and fungi was observed.
【0118】(2)皮膚刺激性の評価
実施例5〜19について、男性パネラー35名を用い
て、48時間閉塞貼付試験を行い、表6に示す判定基準
により評価し、35名の皮膚刺激指数の平均値を求め
た。なお、実施例15〜19については、1.0質量%
水溶液を試験に用いた。(2) Evaluation of skin irritation For Examples 5 to 19, a 35-hour male patcher was used for a 48-hour occlusion patch test, and the skin irritation index of 35 people was evaluated by the criteria shown in Table 6. Was calculated. In addition, about Examples 15-19, 1.0 mass%
The aqueous solution was used for the test.
【0119】[0119]
【表6】 [Table 6]
【0120】(3)使用時の不快感の評価
女性パネラー20名を1群とし、各群に実施例5〜19
のそれぞれを使用させ、塗布後30秒から1分間の間に
感じる差すような痛み、ヒリヒリ感、チクチク感といっ
た不快感について評価させた。(3) Evaluation of discomfort during use 20 female panelists were set as one group, and each group was treated with Examples 5 to 19
Each of them was used and evaluated for discomfort such as a tingling sensation, tingling sensation, and tingling sensation during 30 seconds to 1 minute after application.
【0121】評価結果は、 「非常に強く感じる」 = 5点 「やや強く感じる」 = 4点 「感じる」 = 3点 「少し感じる」 = 2点 「微妙に感じる」 = 1点 「感じない」 = 0点 として評価し、20名の平均値で示した。The evaluation result is "I feel very strong" = 5 points "Slightly strong" = 4 points "Feel" = 3 points "Feel a little" = 2 points "I feel delicate" = 1 point "I don't feel" = 0 points Was evaluated and shown as the average value of 20 people.
【0122】この際、実施例15〜19については1.
0質量%水溶液を試験に用いた。結果を下記表にまとめ
て示す。At this time, for Examples 15 to 19, 1.
A 0 mass% aqueous solution was used for the test. The results are summarized in the table below.
【表7】 [Table 7]
【0123】表7から、本発明の実施例5〜19につい
ては、いずれにおいても皮膚疾患予防治療剤刺激性は認
められず、使用時の不快感も僅かに感じられる程度であ
る。このように、本発明により抗菌作用が増強され、し
かも皮膚刺激性のみならず、使用時の不快感もほとんど
感じられない抗菌性低刺激化粧料を得ることができる。From Table 7, in any of Examples 5 to 19 of the present invention, no irritation to the skin disease preventive / therapeutic agent was observed, and discomfort during use was slightly felt. Thus, according to the present invention, it is possible to obtain an antibacterial hypoallergenic cosmetic composition which has an enhanced antibacterial effect and is not only irritating to the skin, but also hardly causes discomfort during use.
【0124】[0124]
【発明の効果】本発明の抗菌性化粧料組成物は、ヒトや
環境に対して極めて安全であるアイチュリン系ペプチド
により化粧品の微生物汚染に対する安定性を飛躍的に高
めると共に、化粧品に含まれるビタミン他の脂溶性の機
能成分の皮膚浸透性を高め、その効果を増強することが
できる。EFFECTS OF THE INVENTION The antibacterial cosmetic composition of the present invention dramatically improves the stability of cosmetics against microbial contamination by the iturin-based peptide, which is extremely safe for humans and the environment. It is possible to enhance the skin permeability of the fat-soluble functional ingredient of and enhance its effect.
【0125】[0125]
【図1】本発明の抗菌性化粧料組成物を用いたカビ発育
試験の一例を示す装置図。FIG. 1 is an apparatus diagram showing an example of a mold growth test using the antibacterial cosmetic composition of the present invention.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 7/032 A61K 7/032 7/035 7/035 7/06 7/06 7/08 7/08 7/50 7/50 (72)発明者 続木 敏 千葉県千葉市緑区大野台一丁目1番1号 昭和電工株式会社総合研究所内 (72)発明者 小方 英二 千葉県千葉市緑区大野台一丁目1番1号 昭和電工株式会社総合研究所内 Fターム(参考) 4C083 AA082 AA112 AB032 AB232 AB242 AB332 AB432 AB442 AC012 AC022 AC072 AC102 AC122 AC172 AC242 AC342 AC392 AC422 AC432 AC442 AC542 AC642 AC692 AC792 AD092 AD112 AD152 AD272 AD411 AD412 AD611 CC02 CC04 CC05 CC11 CC12 CC14 CC23 CC33 DD27 DD32 DD33 DD41 EE14 ─────────────────────────────────────────────────── ─── Continuation of front page (51) Int.Cl. 7 Identification code FI theme code (reference) A61K 7/032 A61K 7/032 7/035 7/035 7/06 7/06 7/08 7/08 7 / 50 7/50 (72) Inventor Satoshi Tsugi, 1-1 1-1 Onodai, Midori-ku, Chiba, Chiba Prefecture, Showa Denko K.K. (72) Eiji Ogata 1-1, Onodai, Midori-ku, Chiba, Chiba Prefecture No. 1 Showa Denko Co., Ltd. Research Institute F-term (reference) 4C083 AA082 AA112 AB032 AB232 AB242 AB332 AB432 AB442 AC012 AC022 AC072 AC102 AC122 AC172 AC242 AC342 AC392 AC422 AC432 AC442 AC542 AC642 AC692 AC792 AD092 AD112 AD152 AD272 AD411 AD412 AD611 CC02 CC04 CC04 CC04 CC04 CC04 CC04 CC04 CC04 CC11 CC12 CC14 CC23 CC33 DD27 DD32 DD33 DD41 EE14
Claims (6)
抗菌性化粧料組成物。1. An antibacterial cosmetic composition comprising an iturin peptide as an active ingredient.
示される化合物である請求項1に記載の抗菌性化粧料組
成物。 【化1】 (式(1)中、Rは炭素鎖3〜10の直鎖又は分岐上の
アルキル基を表す。)2. The antibacterial cosmetic composition according to claim 1, wherein the iturin peptide is a compound represented by the general formula (1). [Chemical 1] (In the formula (1), R represents a linear or branched alkyl group having 3 to 10 carbon chains.)
ることを特徴とする請求項1または2に記載の抗菌性化
粧料組成物。3. The antibacterial cosmetic composition according to claim 1 or 2, which contains a fat-soluble vitamin or a derivative thereof.
性化粧料組成物を含有する化粧料。4. A cosmetic containing the antibacterial cosmetic composition according to any one of claims 1 to 3.
性化粧料組成物を含有する皮膚用剤。5. A skin preparation containing the antibacterial cosmetic composition according to any one of claims 1 to 3.
療剤である請求項5に記載の皮膚用剤。6. The skin preparation according to claim 5, which is a prophylactic or therapeutic agent for acne and atopic dermatitis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001308631A JP2003113040A (en) | 2001-10-04 | 2001-10-04 | Antibacterial cosmetic composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001308631A JP2003113040A (en) | 2001-10-04 | 2001-10-04 | Antibacterial cosmetic composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2003113040A true JP2003113040A (en) | 2003-04-18 |
Family
ID=19127909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001308631A Pending JP2003113040A (en) | 2001-10-04 | 2001-10-04 | Antibacterial cosmetic composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2003113040A (en) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003277250A (en) * | 2002-03-26 | 2003-10-02 | Kanebo Ltd | Skin care preparation |
| JP2005053785A (en) * | 2003-05-20 | 2005-03-03 | Nippon Menaade Keshohin Kk | External preparation |
| JP2005232050A (en) * | 2004-02-18 | 2005-09-02 | Rikogaku Shinkokai | Reagent having antimicrobial action |
| WO2012096257A1 (en) * | 2011-01-12 | 2012-07-19 | 株式会社ライフアートビレッジ | Hair growth stimulant |
| KR101608687B1 (en) | 2009-07-31 | 2016-04-05 | (주)아모레퍼시픽 | Cosmetic composition containing cyclic lipopeptide for antioxidant and antiaging |
| JP2017078041A (en) * | 2015-10-20 | 2017-04-27 | ケミコスクリエイションズ株式会社 | Liquid cosmetic composition |
| WO2017209241A1 (en) * | 2016-06-01 | 2017-12-07 | 株式会社カネカ | Emulsified composition and cosmetic using same |
| WO2018052084A1 (en) * | 2016-09-14 | 2018-03-22 | 株式会社カネカ | Gel-like composition, and external-use agent for skin and cosmetic material in which said gel-like composition is used |
| JP2019202975A (en) * | 2018-05-25 | 2019-11-28 | 桂 嶋田 | Adhesive for eyelash extension |
| CN110831571A (en) * | 2017-05-07 | 2020-02-21 | 轨迹Ip有限责任公司 | Cosmetic composition for skin health and method of use |
| JP2020527348A (en) * | 2017-07-21 | 2020-09-10 | リポファブリックLipofabrik | Composition containing high concentration of itulin-based lipopeptide |
| CN111773155A (en) * | 2020-07-10 | 2020-10-16 | 陕西慧康生物科技有限责任公司 | A kind of active substance stabilized peptide containing fermentation origin |
| CN117947021A (en) * | 2024-03-27 | 2024-04-30 | 北京瑞贝怡可生物科技有限公司 | Nucleic acid extraction lysis binding solution, nucleic acid extraction kit and extraction method |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05186328A (en) * | 1992-01-13 | 1993-07-27 | Kao Corp | Skin washing and cleanly wiping agent composition |
| JPH07118169A (en) * | 1993-08-30 | 1995-05-09 | Higeta Shoyu Co Ltd | Antibacterial preparation and antimycotic preparation |
| JPH07143897A (en) * | 1993-09-30 | 1995-06-06 | Higeta Shoyu Co Ltd | Production of iturin a and anti-deep mycosis agent |
| JPH11322630A (en) * | 1998-05-08 | 1999-11-24 | Nippon Zetokku Kk | Antimicrobial agent, external preparation for skin and skin cleaning agent containing the same |
| JP2000327591A (en) * | 1998-05-29 | 2000-11-28 | Showa Denko Kk | Surfactant for skin preparation for external use and skin preparation for external use containing the same |
| JP2001226213A (en) * | 1999-12-06 | 2001-08-21 | Shiseido Co Ltd | Selective antimicrobial composition |
-
2001
- 2001-10-04 JP JP2001308631A patent/JP2003113040A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05186328A (en) * | 1992-01-13 | 1993-07-27 | Kao Corp | Skin washing and cleanly wiping agent composition |
| JPH07118169A (en) * | 1993-08-30 | 1995-05-09 | Higeta Shoyu Co Ltd | Antibacterial preparation and antimycotic preparation |
| JPH07143897A (en) * | 1993-09-30 | 1995-06-06 | Higeta Shoyu Co Ltd | Production of iturin a and anti-deep mycosis agent |
| JPH11322630A (en) * | 1998-05-08 | 1999-11-24 | Nippon Zetokku Kk | Antimicrobial agent, external preparation for skin and skin cleaning agent containing the same |
| JP2000327591A (en) * | 1998-05-29 | 2000-11-28 | Showa Denko Kk | Surfactant for skin preparation for external use and skin preparation for external use containing the same |
| JP2001226213A (en) * | 1999-12-06 | 2001-08-21 | Shiseido Co Ltd | Selective antimicrobial composition |
Cited By (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003277250A (en) * | 2002-03-26 | 2003-10-02 | Kanebo Ltd | Skin care preparation |
| JP2005053785A (en) * | 2003-05-20 | 2005-03-03 | Nippon Menaade Keshohin Kk | External preparation |
| JP2005232050A (en) * | 2004-02-18 | 2005-09-02 | Rikogaku Shinkokai | Reagent having antimicrobial action |
| KR101608687B1 (en) | 2009-07-31 | 2016-04-05 | (주)아모레퍼시픽 | Cosmetic composition containing cyclic lipopeptide for antioxidant and antiaging |
| WO2012096257A1 (en) * | 2011-01-12 | 2012-07-19 | 株式会社ライフアートビレッジ | Hair growth stimulant |
| JPWO2012096257A1 (en) * | 2011-01-12 | 2014-06-09 | 株式会社ライフアートビレッジ | Hair restorer |
| JP2017078041A (en) * | 2015-10-20 | 2017-04-27 | ケミコスクリエイションズ株式会社 | Liquid cosmetic composition |
| WO2017209241A1 (en) * | 2016-06-01 | 2017-12-07 | 株式会社カネカ | Emulsified composition and cosmetic using same |
| EP3508191A4 (en) * | 2016-09-14 | 2019-09-11 | Kaneka Corporation | GEL-TYPE COMPOSITION AND EXTERNAL USE AGENT FOR SKIN AND COSMETIC MATERIAL IN WHICH THE GEL-TYPE COMPOSITION IS USED |
| WO2018052084A1 (en) * | 2016-09-14 | 2018-03-22 | 株式会社カネカ | Gel-like composition, and external-use agent for skin and cosmetic material in which said gel-like composition is used |
| US10758460B2 (en) | 2016-09-14 | 2020-09-01 | Kaneka Corporation | Gel-like composition, and external-use agent for skin and cosmetic material in which said gel-like composition is used |
| JPWO2018052084A1 (en) * | 2016-09-14 | 2019-04-04 | 株式会社カネカ | Gel-like composition, and external preparation for skin and cosmetics using the same |
| US11446235B2 (en) | 2017-05-07 | 2022-09-20 | Locus Ip Company, Llc | Cosmetic compositions for skin health and methods of using same |
| JP7504790B2 (en) | 2017-05-07 | 2024-06-24 | ローカス アイピー カンパニー、エルエルシー | Cosmetic compositions for skin health and methods of use thereof |
| CN110831571A (en) * | 2017-05-07 | 2020-02-21 | 轨迹Ip有限责任公司 | Cosmetic composition for skin health and method of use |
| JP2020518667A (en) * | 2017-05-07 | 2020-06-25 | ローカス アイピー カンパニー、エルエルシー | Cosmetic composition for skin health and method of using the same |
| JP2023061924A (en) * | 2017-05-07 | 2023-05-02 | ローカス アイピー カンパニー、エルエルシー | COSMETIC COMPOSITION FOR SKIN HEALTH AND USE THEREOF |
| JP2020527348A (en) * | 2017-07-21 | 2020-09-10 | リポファブリックLipofabrik | Composition containing high concentration of itulin-based lipopeptide |
| JP7616562B2 (en) | 2017-07-21 | 2025-01-17 | リポファブリック | Compositions containing high concentrations of iturin-based lipopeptides |
| JP2019202975A (en) * | 2018-05-25 | 2019-11-28 | 桂 嶋田 | Adhesive for eyelash extension |
| CN111773155B (en) * | 2020-07-10 | 2022-11-04 | 陕西慧康生物科技有限责任公司 | A kind of active substance stabilized peptide containing fermentation origin |
| CN111773155A (en) * | 2020-07-10 | 2020-10-16 | 陕西慧康生物科技有限责任公司 | A kind of active substance stabilized peptide containing fermentation origin |
| CN117947021A (en) * | 2024-03-27 | 2024-04-30 | 北京瑞贝怡可生物科技有限公司 | Nucleic acid extraction lysis binding solution, nucleic acid extraction kit and extraction method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4111856B2 (en) | Stabilized ascorbic acid derivatives | |
| JP5996156B2 (en) | Gene expression promoter for skin beautification, moisturizing composition and skin beautifying composition using the same | |
| JP5113371B2 (en) | Hydrolyzate of water-soluble polysaccharide derived from white jellyfish, antioxidant containing the same, cosmetic or skin external preparation, food | |
| JP6803732B2 (en) | Cosmetics containing γ-oryzanol | |
| JP2003128512A (en) | Antibacterial composition for cosmetic | |
| JP2008291004A (en) | Skin care composition | |
| JP2020083771A (en) | Antibacterial or antiseptic | |
| JP2019189556A (en) | Phosphatidylinositol-containing complex | |
| JP2006028148A (en) | Composition for external use | |
| JP2018058813A (en) | Antisepsis antimicrobial agent for cosmetics | |
| JP2003113040A (en) | Antibacterial cosmetic composition | |
| JP2008088123A (en) | Skin care composition | |
| JP2004250690A (en) | Antioxidant composition and topical composition | |
| JP4574384B2 (en) | Skin preparation for promoting collagen production | |
| JP2003063926A (en) | Composition for beautiful skin | |
| JP4377263B2 (en) | Cosmetics and external preparation for skin | |
| JP6144536B2 (en) | Whitening agent | |
| JP2002265348A (en) | Composition for external use | |
| JP2010043041A (en) | Cosmetic composition | |
| JP2018002702A (en) | Carbonylation inhibitor | |
| JP2017132703A (en) | Carbonylation inhibitor | |
| JP2005179286A (en) | Utilization of hyaluronic acid synthesis-promoting agent to skin aging-preventing agent | |
| JP2007314472A (en) | Body odor suppressor | |
| JP2011225785A (en) | Antioxidant composition and beverage using the same, pharmaceuticals, and quasi drug | |
| JP2012171906A (en) | Agent for preventing skin photoaging |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040805 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20050524 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050607 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20051018 |